<!DOCTYPE html>
<html lang="en">
<head>
  <title>
    eCFR :: 21 CFR Part 606 -- Current Good Manufacturing Practice for Blood and Blood Components
  </title>

  <link rel="canonical" href="https://www.ecfr.gov/current/title-21/chapter-I/subchapter-F/part-606" />

  <link rel="apple-touch-icon" sizes="180x180" href="/assets/favicon/apple-touch-icon-18ac1159c2217e79fb45c21adc630384b65af33c4e6de8eca0ff8527a4fe080e.png">
<link rel="icon" type="image/png" sizes="32x32" href="/assets/favicon/favicon-32x32-601e211398bdd3b5d26f99ae1ddae16e940b6a6223cb83f429419e6709f596f2.png">
<link rel="icon" type="image/png" sizes="16x16" href="/assets/favicon/favicon-16x16-8e7cf46953c8eadd70c27e99d2977556a7ad517c1d809782451b24be80323d14.png">
<link rel="manifest" href="/assets/favicon/site-17bc871d6b501401cd30d1f57e54a581f21f9c964717dd77d28e6f026da4b560.webmanifest">
<link rel="mask-icon" href="/assets/favicon/safari-pinned-tab-42724ccbb4192754e3500f02bee26d07b1c8432d7179433dd34d8d59c4e0882b.svg" color="#fab827">
<link rel="shortcut icon" href="/assets/favicon/favicon-014ef9fe5cc7969da15185d0790dba54c9c41bbcedda5477f9a7214d98263525.ico">
<meta name="msapplication-TileColor" content="#ffc40d">
<meta name="msapplication-config" content="/assets/favicon/browserconfig-d9fe2961ea6e1d05b91dec740f2c7b3b916c646691e7c909c258dea3ad28cd94.xml">
<meta name="theme-color" content="#ffffff">


    <!-- Global site tag (gtag.js) - Google Analytics -->
    <script src="/assets/google_analytics-a2da3bb5c78c39ec6f425a2de69612f49200191a66f6aaac3b373bc53618cf0e.js" async="async" nonce="ubosFkJwWeCg3IbvrCoL0Q=="></script>

    <!-- We participate in the US government's analytics program. See the data at analytics.usa.gov. -->
    <script async type="text/javascript" nonce="ubosFkJwWeCg3IbvrCoL0Q==" src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=NARA&subagency=fedreg" id="_fed_an_ua_tag"></script>

  <link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link
href="https://fonts.googleapis.com/css2?family=Roboto:ital,wght@0,400;0,500;0,600;0,700;1,400;1,500;1,700&family=Bitter:ital,wght@0,400;0,500;0,700;1,400;1,500;1,700&display=swap"
rel="preload"
as="style">
<link
href="https://fonts.googleapis.com/css2?family=Roboto:ital,wght@0,400;0,500;0,600;0,700;1,400;1,500;1,700&family=Bitter:ital,wght@0,400;0,500;0,700;1,400;1,500;1,700&display=swap"
rel="stylesheet">


  <link rel="stylesheet" media="all" href="/assets/vendor-ed1f17021e0f5e5ba9861e9a88550a0d17aa9657d0832f953e6156a822fe3a1d.css" data-turbo-track="true" />
  <link rel="stylesheet" media="all" href="/assets/application-cab3fe704abacf30de204627077d84af75f499a7a95a6ebf38ab9f441d80db4b.css" data-turbo-track="true" />
  <link rel="stylesheet" media="print" href="/assets/print-e85ef07360cd8210c510308470ec9745d5d7b31065d9007a9d9b6935c561c232.css" data-turbo-track="true" />

  <script src="/assets/application_pipeline-662bba96b1118fe94244c70ca2c6a5043f8d3e1ea30f8a9d57d521ce1c692105.js" data-turbo-eval="false" async="async" defer="defer" nonce="ubosFkJwWeCg3IbvrCoL0Q=="></script>

  <script type="importmap" data-turbo-track="reload" nonce="ubosFkJwWeCg3IbvrCoL0Q==">{
  "imports": {
    "application": "/assets/application-335c9d0168c1b2a3960dd56fdf4f6c209d0eec1942adb72b6441483bed14e77f.js",
    "@hotwired/turbo-rails": "/assets/turbo.min-f971c8640d593387ea5afa6f0b3f51d9868c8ab3b4ddf1c811da0ed00d67af2d.js",
    "@hotwired/stimulus": "https://ga.jspm.io/npm:@hotwired/stimulus@3.2.2/dist/stimulus.js",
    "@hotwired/stimulus-loading": "/assets/stimulus-loading-6024ee603e0509bba59098881b54a52936debca30ff797835b5ec6a4ef77ba37.js",
    "@lodash/debounce": "https://ga.jspm.io/npm:lodash.debounce@4.0.8/index.js",
    "stimulus-autocomplete": "/assets/stimulus-autocomplete-0e2d350d1a0100abce1840193618fa0e606c0425d5631eb27dee0fb068cc32df.js",
    "stimulus-use": "https://ga.jspm.io/npm:stimulus-use@0.52.0/dist/index.js",
    "controllers/agencies_controller": "/assets/controllers/agencies_controller-b39755bd0bdc29806a7e88bb2015c8cb873f41228c3332df2a9a0b91e94af87c.js",
    "controllers/application": "/assets/controllers/application-e361dd5f2e228c2fb25a1549ad19f7ab2ee254e8123572f3fb9694ad08711254.js",
    "controllers/changes_controller": "/assets/controllers/changes_controller-7d46a5241e38838956e42fa95fe3b8a38901c1c5c739c623498328449cb8f6d1.js",
    "controllers/compare_controller": "/assets/controllers/compare_controller-d4c7c2f7183e9a0487fb4156d3be50ca77ced0e1881289fbe3b0920b4a88ec95.js",
    "controllers/element_controller": "/assets/controllers/element_controller-124c5e519399db700016351f28875d1aebd96b8966ef7655beb3e8ec42529c3e.js",
    "controllers/form_controller": "/assets/controllers/form_controller-521a8ae5e19bf25bcf358a35c386589c4ae49399968da815af3e5fedb4e66cad.js",
    "controllers": "/assets/controllers/index-075d84f1ecd1595c9ab3e04d66cb668dc9f6fb81d4809c437cbb0a5c0ec6fce2.js",
    "controllers/modal_controller": "/assets/controllers/modal_controller-b9cff36cd77bfb60e03304caa4eecacff19fc3713510141975d9e6f2748ac706.js",
    "controllers/placeholder_controller": "/assets/controllers/placeholder_controller-db5bbdf7df068e036eb77a730c74a68b59d680045962165deb575098d64ea172.js",
    "controllers/recent_changes_controller": "/assets/controllers/recent_changes_controller-b55783709d43d67c169ce404aad187bb8a49f140d816a203405cc382ae31d605.js",
    "controllers/suggestions_controller": "/assets/controllers/suggestions_controller-c86bd514065aba875525a390293adf8e27176ccdd869a92a035c06b027e67771.js",
    "controllers/timeline_controller": "/assets/controllers/timeline_controller-d797067edc737523ee3485893dd7f9f0e658d0e421b93ec3657bd7dcf6d9d1d2.js"
  }
}</script>
<link rel="modulepreload" href="/assets/application-335c9d0168c1b2a3960dd56fdf4f6c209d0eec1942adb72b6441483bed14e77f.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/turbo.min-f971c8640d593387ea5afa6f0b3f51d9868c8ab3b4ddf1c811da0ed00d67af2d.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="https://ga.jspm.io/npm:@hotwired/stimulus@3.2.2/dist/stimulus.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/stimulus-loading-6024ee603e0509bba59098881b54a52936debca30ff797835b5ec6a4ef77ba37.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="https://ga.jspm.io/npm:lodash.debounce@4.0.8/index.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/stimulus-autocomplete-0e2d350d1a0100abce1840193618fa0e606c0425d5631eb27dee0fb068cc32df.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="https://ga.jspm.io/npm:stimulus-use@0.52.0/dist/index.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/controllers/agencies_controller-b39755bd0bdc29806a7e88bb2015c8cb873f41228c3332df2a9a0b91e94af87c.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/controllers/application-e361dd5f2e228c2fb25a1549ad19f7ab2ee254e8123572f3fb9694ad08711254.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/controllers/changes_controller-7d46a5241e38838956e42fa95fe3b8a38901c1c5c739c623498328449cb8f6d1.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/controllers/compare_controller-d4c7c2f7183e9a0487fb4156d3be50ca77ced0e1881289fbe3b0920b4a88ec95.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/controllers/element_controller-124c5e519399db700016351f28875d1aebd96b8966ef7655beb3e8ec42529c3e.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/controllers/form_controller-521a8ae5e19bf25bcf358a35c386589c4ae49399968da815af3e5fedb4e66cad.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/controllers/index-075d84f1ecd1595c9ab3e04d66cb668dc9f6fb81d4809c437cbb0a5c0ec6fce2.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/controllers/modal_controller-b9cff36cd77bfb60e03304caa4eecacff19fc3713510141975d9e6f2748ac706.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/controllers/placeholder_controller-db5bbdf7df068e036eb77a730c74a68b59d680045962165deb575098d64ea172.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/controllers/recent_changes_controller-b55783709d43d67c169ce404aad187bb8a49f140d816a203405cc382ae31d605.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/controllers/suggestions_controller-c86bd514065aba875525a390293adf8e27176ccdd869a92a035c06b027e67771.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<link rel="modulepreload" href="/assets/controllers/timeline_controller-d797067edc737523ee3485893dd7f9f0e658d0e421b93ec3657bd7dcf6d9d1d2.js" nonce="ubosFkJwWeCg3IbvrCoL0Q==">
<script type="module" nonce="ubosFkJwWeCg3IbvrCoL0Q==">import "application"</script>

  

  <meta name="viewport" content="width=970">
  <meta name="format-detection" content="telephone=no">
    <meta name="dcterms.title"
    content="21 CFR Part 606 -- Current Good Manufacturing Practice for Blood and Blood Components" />
	<meta name="dcterms.bibliographicCitation"
    content="21 CFR Part 606" />

  <meta property="og:title"
    content="21 CFR Part 606 -- Current Good Manufacturing Practice for Blood and Blood Components" />
  <meta property="og:url"
    content="/current/title-21/part-606" />

  <meta property="ecfr:citationDate"
    content="" />


</head>
  <body data-environment="production" data-honeybadger-js-api-key="f722cff2" data-revision="fe90b535b988cdb7ef5a8c4f0a288eb096501233" data-google-ga4-tag="G-K7SMYBYX81" data-service="ecfr-web" data-domain=".ecfr.gov">

    <!-- Zendesk Form -->
      <div class="btn" id="feedbackbutton" type="button"><span class="icon-ecfr-chat"></span>Site Feedback</div>
      <div id="legacy_browser_modal" class="modal fade" role="dialog" aria-labelledby="genericModal" aria-hidden="true" tabindex="-1">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">You are using an unsupported browser
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
        <span aria-hidden="true">&times;</span>
        </h5>
      </div>
      <div class="modal-body">
        <p>
          You are using an unsupported browser. This web site is designed for the current versions of
          Microsoft Edge, Google Chrome, Mozilla Firefox, or Safari.
        </p>
      </div>
    </div>
  </div>
</div>

      <div id="interstitial-feedback-modal" class="modal fade in" aria-hidden="true" tabindex="-1" role="dialog" aria-labelledby="Feedback: Contact Us">
  <div class="modal-dialog" role="document">
    <div class="modal-content">
      <div class="modal-header">
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">×</span>
        </button>
        <h3 class="text-center">Site Feedback</h3>
      </div>
      <div class="modal-body">
        <p>
          The Office of the Federal Register publishes documents on behalf of Federal agencies but does not have any authority over their programs. We recommend you directly contact the agency associated with the content in question.
        </p>
        <hr>
        <div class="row">
          <div id="website-feedback" class="col-xs-6 col-md-6 feedback-section">
            <p>
              If you have comments or suggestions on how to improve the www.ecfr.gov website or have questions about using www.ecfr.gov, please choose the 'Website Feedback' button below.
            </p>
            <div class="text-center">
              <a class="btn btn-primary btn-medium text-center" href="">
                <div><span class="icon-ecfr icon-ecfr-help "></span></div>
                Website Feedback
</a>            </div>
          </div>
          <div id="content-feedback" class="col-xs-6 col-md-6 feedback-section">
            <p>
              If you would like to comment on the current content, please use the 'Content Feedback' button below for instructions on contacting the issuing agency
            </p>
            <div class="text-center">
              <a class="btn btn-primary btn-medium text-center" href="">
                <div><span class="icon-ecfr icon-ecfr-legal "></span></div>
                Content Feedback
</a>            </div>
          </div>
        </div>
        <div class="text-center small-text">If you have questions for the Agency that issued the current document please contact the agency directly.</div>
      </div>
    </div>
  </div>
</div>

      <div id="zendesk-feedback-modal">
  <div class="modal-content zendesk-modal-content">
    <div class="modal-header">
      <button type="button" class="close" data-dismiss="modal" aria-label="Close">
        <span aria-hidden="true">×</span>
      </button>
      <h3>Website Feedback</h3>
    </div>

    <div class="modal-body">
      <form novalidate="novalidate" class="simple_form zendesk_ticket" enctype="multipart/form-data" action="/zendesk_tickets" accept-charset="UTF-8" method="post">
        <div class="form-group string required zendesk_ticket_name"><label class="control-label string required" for="zendesk_ticket_name"><abbr title="required">*</abbr> Your Name</label><input class="form-control string required" required="required" aria-required="true" type="text" name="zendesk_ticket[name]" id="zendesk_ticket_name" /></div>
        <div class="form-group email required zendesk_ticket_email"><label class="control-label email required" for="zendesk_ticket_email"><abbr title="required">*</abbr> Email</label><input class="form-control string email required" required="required" aria-required="true" type="email" name="zendesk_ticket[email]" id="zendesk_ticket_email" /></div>
        <div class="form-group file optional zendesk_ticket_attachment"><label class="control-label file optional" for="zendesk_ticket_attachment">Attachment</label><input class="file optional" type="file" name="zendesk_ticket[attachment]" id="zendesk_ticket_attachment" /></div>
        <div class="form-group text required zendesk_ticket_comment"><label class="control-label text required" for="zendesk_ticket_comment"><abbr title="required">*</abbr> How can we help you?</label><textarea class="form-control text required" name="zendesk_ticket[comment]" id="zendesk_ticket_comment">
</textarea></div>
        <div class="form-group boolean required zendesk_ticket_technical_help"><div class="checkbox"><input value="0" autocomplete="off" type="hidden" name="zendesk_ticket[technical_help]" /><label class="boolean required" for="zendesk_ticket_technical_help"><input class="boolean required" required="required" aria-required="true" type="checkbox" value="1" name="zendesk_ticket[technical_help]" id="zendesk_ticket_technical_help" /><abbr title="required">*</abbr> I am requesting technical help or providing website feedback</label></div></div>
          <div class="modal-text">
            This contact form is only for website help or website suggestions. If you have questions or comments regarding a published document please
            contact the publishing agency. Comments or questions about document content can not be answered by OFR staff. Please do not provide confidential
            information or personal data.
          </div>
        <div class="form-group text-left">
          <input type="submit" name="commit" value="Create Ticket" class="btn btn-primary btn-medium" data-disable-with="Create Ticket" />
        </div>
</form>    </div>
  </div>
</div>


    

    <div class="container">
      <div class='row'>
        <div class="col-xs-12 col-md-12 layout-header">
          <div class="main-navigation" id="main-navigation">
  <ul class="container">
    <li id='nav-home' class="nav-home" tabindex>
      <a class="home" aria-label="Home" href="/">
        <span class="icon-ecfr icon-ecfr-home "></span>
</a>    </li>

    <li id='nav-browse' class="dropdown nav-browse" tabindex=0>
      <a class="top-nav">
        <span class="icon-ecfr icon-ecfr-eye "></span>
        Browse
        <span class="icon-ecfr icon-ecfr-menu-arrow "></span>
      </a>

      <ul class="subnav dropdown-list">
        <li>
          <a href="/titles"><span class="icon-ecfr icon-ecfr-book "></span> Titles</a>
        </li>
        <li>
          <a href="/agencies"><span class="icon-ecfr icon-ecfr-mindmap "></span> Agencies</a>
        </li>
        <li>
          <a href="/incorporation-by-reference"><span class="icon-ecfr icon-ecfr-directions-alt "></span> Incorporation by Reference</a>
        </li>
        <li>
          <a href="/issues"><span class="icon-ecfr icon-ecfr-hourglass "></span> Recent Updates</a>
        </li>
      </ul>
    </li>

    <li id='nav-search' class="nav-search" tabindex>
      <a class="search" aria-label="eCFR Search" href="/search">
        <span class="icon-ecfr icon-ecfr-search "></span> Search
</a>    </li>

    <li id='nav-recent-changes' class="nav-recent-changes" tabindex>
      <a aria-label="eCFR Recent Changes" href="/recent-changes">
        <span class="icon-ecfr icon-ecfr-hourglass "></span> Recent Changes
</a>    </li>

    <li id='nav-ecfr-corrections' class="nav-recent-changes" tabindex>
      <a aria-label="eCFR Corrections" href="/corrections/2025">
        <span class="icon-ecfr icon-ecfr-merge "></span> Corrections
</a>    </li>

    <li id='nav-reader-aids' class="dropdown nav-reader-aids" tabindex=0>
      <a class="top-nav">
        <span class="icon-ecfr icon-ecfr-directions "></span>
        Reader Aids
        <span class="icon-ecfr icon-ecfr-menu-arrow "></span>
      </a>

      <ul class="subnav dropdown-list hierarchical" tabindex=0>
        <li>
          <a tabindex="0" href="/reader-aids">Reader Aids Home</a>
        </li>
          <li>
            <a tabindex="0" href="/reader-aids/using-ecfr">Using the eCFR Point-in-Time System</a>
          </li>
          <li>
            <a tabindex="0" href="/reader-aids/understanding-the-ecfr">Understanding the eCFR</a>
          </li>
          <li>
            <a tabindex="0" href="/reader-aids/government-policy-and-ofr-procedures">Government Policy and OFR Procedures</a>
          </li>
          <li>
            <a tabindex="0" href="/reader-aids/ecfr-developer-resources">Developer Resources</a>
          </li>
      </ul>
    </li>

    <li id='nav-my-ecfr' class="dropdown nav-my-ecfr" tabindex=0>
      <a class="top-nav">
        <span class="icon-ecfr icon-ecfr-male-female-user "></span>
        My eCFR
        <span class="icon-ecfr icon-ecfr-menu-arrow "></span>
      </a>

      <ul class="subnav dropdown-list signed-in hidden" tabindex=0>
        <li>
          <a href="/my/subscriptions">My Subscriptions</a>
        </li>
        <li>
          <a data-turbo="false" href="/sign_out">Sign Out</a>
        </li>
      </ul>

      <ul class="subnav dropdown-list signed-out" tabindex=0>
        <li>
          <a data-turbo="false" href="https://www.ecfr.gov/auth/sign_in?jwt=eyJhbGciOiJIUzI1NiJ9.eyJub3RpZmljYXRpb25zIjp7ImluZm8iOiJZb3Ugd2lsbCBiZSByZWRpcmVjdGVkIGJhY2sgdG8gdGhlIGVDRlIgYWZ0ZXIgeW91IGhhdmUgc2lnbmVkIGluIG9yIGNyZWF0ZWQgYW4gYWNjb3VudC4ifX0.-sYkHWfC02yb0CpuUqmPkxxnF0yzlNHaS5520hYIUy8&amp;redirect_to=https://www.ecfr.gov/current/title-21/chapter-I/subchapter-F/part-606">Sign In / Sign Up</a>
        </li>
      </ul>
    </li>

    <li id='nav-inline-search' class="nav-inline-search" data-controller="placeholder">
      <form class="simple_form nav-search-form" novalidate="novalidate" action="/search" accept-charset="UTF-8" method="get">
        <input value="current" class="hidden" autocomplete="off" type="hidden" name="search[date]" id="search_date" />

          <input value="{&quot;title&quot;:&quot;21&quot;,&quot;chapter&quot;:&quot;I&quot;,&quot;subchapter&quot;:&quot;F&quot;,&quot;part&quot;:&quot;606&quot;}" autocomplete="off" type="hidden" name="search[prior_hierarchy]" id="search_prior_hierarchy" />

        <input autocomplete="off" class="string required nav-search-query" data-action="click-&gt;placeholder#suggestions" placeholder="Search the eCFR" type="text" name="search[query]" id="search_query" />

        <button name="button" type="submit" class="nav-search-btn" title="Search" data-action="click-&gt;placeholder#suggestions">
          <span class="icon-ecfr icon-ecfr-search "></span>
</button>
        <div class='current-hierarchy-dropdown hidden'>
        </div>
</form>    </li>
  </ul>

  <div class='user-utils'>
    <div class='signed-out'>
      <a class="utils-signed-out" tabindex="-1" data-turbo="false" href="https://www.ecfr.gov/auth/sign_in?jwt=eyJhbGciOiJIUzI1NiJ9.eyJub3RpZmljYXRpb25zIjp7ImluZm8iOiJZb3Ugd2lsbCBiZSByZWRpcmVjdGVkIGJhY2sgdG8gdGhlIGVDRlIgYWZ0ZXIgeW91IGhhdmUgc2lnbmVkIGluIG9yIGNyZWF0ZWQgYW4gYWNjb3VudC4ifX0.-sYkHWfC02yb0CpuUqmPkxxnF0yzlNHaS5520hYIUy8&amp;redirect_to=https://www.ecfr.gov/current/title-21/chapter-I/subchapter-F/part-606">Sign In / Sign Up</a>
    </div>

    <div class='signed-in hidden'>
      <p>
        Hi, <span class='user-email'></span>
          <a data-turbo="false" tabindex="-1" href="/sign_out">Sign Out</a>
      </p>
    </div>
  </div>
</div>


<div class="container">
  <div class="row">
    <div class="col-xs-12">
      <div class="logo">
        <div class="hgroup standard">
          <hgroup>
            <h1><a href="/" title="eCFR Home" tabindex=-1>eCFR</a></h1>
            <h2>The Electronic Code of Federal Regulations</h2>
          </hgroup>
        </div>
      </div>
    </div>
  </div>
</div>


        </div>
      </div>
    </div>

    <div class="container">
      <div class='external-url-modal'></div>
      <div class="modal fr-citation-modal" id="frCitationModal" tabindex="-1" role="dialog" aria-labelledby="Federal Register Citation Modal">
        <div class="modal-dialog" role="document">
          <div class="modal-content">
            <span class="icon-ecfr icon-ecfr-badge-x "></span>
            <div class="box box-enhanced "><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content :: FR Reference</h6><div class="row seal-meta"><div class="seal-desc col-md-12 col-xs-12"><p>Enhanced content is provided to the user to provide additional context.</p></div></div></div></div><div class="content-block ">
              <div class="modal-body"></div>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content :: FR Reference</h6></div></div>          </div>
        </div>
      </div>

      <div class='row'>
        <div class="col-xs-12 col-md-12 title-bar-col">
          <div id="page-top" class="main-title-bar "><div class="bar left"></div><h1 class="">  <span class="icon-ecfr icon-ecfr-books "></span>
  Title 21
</h1><div class="bar right"></div></div>
        </div>
      </div>


          <div class="row " >
  <div class="col-xs-12 col-md-12 content-notification basic print-only print-only-legal-notice"
    id="content-notification-f4223aa6"
  >
    <div class="">

      

      <div class="message">
        <p>This content is from the eCFR and is authoritative but unofficial.<p>
      </div>

    </div>
  </div>
</div>

  <div class="row " >
  <div class="col-xs-12 col-md-12 content-notification info"
    id="content-notification-a4841755"
  >
    <div class="">

      <span class="icon-ecfr icon-ecfr-calendar-alt "></span>

      <div class="message">
        Displaying title 21, up to date as of 4/10/2025. Title 21 was last amended 3/31/2025.<span class="reader-aid"><span data-toggle="tooltip" data-title="Click to learn more about dates in eCFR." class="svg-tooltip clickable" data-url="/reader-aids/understanding-the-ecfr/what-is-the-ecfr#special-rules-and-proceedures-for-future-amendments" data-container="span.reader-aid"><svg class="ecfr-svg-icon ecfr-svg-icon-info-circle "><use xlink:href="/assets/ecfr-icons-c08c495b1eda093da23b5b159c24927a91aa7c13df40f52ca7d30476904de0ea.svg#ecfr-svg-icon-info-circle"></use></svg></span></span>
      </div>

        <div class="message-link">
          <a class="msg-link message-go-to-version" href="#">view historical versions</a>
        </div>
    </div>
  </div>
</div>

  <div class="row hidden" >
  <div class="col-xs-12 col-md-12 content-notification danger"
    id="drafting-site-notification"
  >
    <div class="">
        <div class="dismiss-link">
          <span class="icon-ecfr icon-ecfr-badge-x "></span>
        </div>

      <span class="icon-ecfr icon-ecfr-alert-alt "></span>

      <div class="message">
        A <a data-drafting="true" href="https://drafting.ecfr.gov/current/title-21/chapter-I/subchapter-F/part-606">drafting site is available</a> for use when drafting amendatory language
      </div>

        <div class="message-link">
          <a data-drafting="true" class="msg-link" href="https://drafting.ecfr.gov/current/title-21/chapter-I/subchapter-F/part-606">switch to drafting site</a>
        </div>
    </div>
  </div>
</div>






      <div class='row'>
        <div class="col-xs-12 col-md-12 content-col">
          <div>
  <div id="suggestions" data-controller="suggestions autocomplete"
    data-autocomplete-url-value="/suggestions"
    data-autocomplete-delay-value="300">

    <div class="modal hidden" data-controller="modal"
      data-action="keyup@document->modal#escClose"
      data-suggestions-target="modal">

      <button class="backdrop" type="button" tabindex="-1"
        data-action="modal#close"></button>

      <div class="content">

        <div class="panel panel-default panel-info" data-suggestions-target="help">
          <div class="panel-heading">
            <p>
              <strong>Navigate by entering citations or phrases</strong>
              (eg:
                <span data-action="click->suggestions#fillExample"
                  class="example badge badge-info">1 CFR 1.1</span>
                <span data-action="click->suggestions#fillExample"
                  class="example badge badge-info">49 CFR 172.101</span>
                <span data-action="click->suggestions#fillExample"
                  class="example badge badge-info">Organization and Purpose</span>
                <span data-action="click->suggestions#fillExample"
                  class="example badge badge-info">1/1.1</span>
                <span data-action="click->suggestions#fillExample"
                  class="example badge badge-info">Regulation Y</span>
                <span data-action="click->suggestions#fillExample"
                  class="example badge badge-info">FAR</span>).
            </p>
            <p>
              Choosing an item from
              <span class="suggestion-header-example">citations and headings</span>
              will bring you directly to the content. Choosing an item from
              <span class="suggestion-header-example">full text search results</span>
              will bring you to those results. Pressing enter in the search box
              will also bring you to search results.
            </p>
            <p>
              Background and more details are available in the
              <em>
                <a href="/reader-aids/using-ecfr/navigating-to-content-of-interest#search-navigation">Search &amp; Navigation</a>
              </em>
              guide.
            </p>
          </div>
        </div>

        <div class="cfr-ref-wrapper go-to-cfr-reference">
          <form class="simple_form go-to-cfr-reference" data-suggestions-target="form" data-turbo="false" novalidate="novalidate" action="/cfr-reference" accept-charset="UTF-8" method="get">
            <input value="current" data-param="date" autocomplete="off" type="hidden" name="search[date]" id="search_date" />
            <input value="{&quot;title&quot;:&quot;21&quot;,&quot;chapter&quot;:&quot;I&quot;,&quot;subchapter&quot;:&quot;F&quot;,&quot;part&quot;:&quot;606&quot;}" data-param="hierarchy" autocomplete="off" type="hidden" name="search[hierarchy]" id="search_hierarchy" />
            <input value="{&quot;title&quot;:&quot;21&quot;,&quot;chapter&quot;:&quot;I&quot;,&quot;subchapter&quot;:&quot;F&quot;,&quot;part&quot;:&quot;606&quot;}" data-param="prior_hierarchy" autocomplete="off" type="hidden" name="search[prior_hierarchy]" id="search_prior_hierarchy" />

            <div class="input-group input-group-lg">
              <input type="text" class="form-control"
                placeholder="Enter a search term or CFR reference (eg. fishing or 1 CFR 1.1)"
                aria-describedby="reference-search-icon"
                data-autocomplete-target="input"
                data-suggestions-target="input"
                name="search[query]"
                id="suggestion_query">

              <span class="input-group-btn"
                id="reference-search-icon"
                aria-label="search">
                <button class="btn btn-optional" type="button"
                  data-suggestions-target="searchIcon"
                  data-action="click->suggestions#goDefault">
                    <span class="icon-ecfr icon-ecfr-search "></span>
                </button>
              </span>
            </div>

            <div data-autocomplete-target="results"
              data-suggestions-target="results"></div>
</form>        </div>

      </div>
    </div>

    <form class="simple_form go-to-cfr-reference hidden" data-suggestions-target="nonModalForm" novalidate="novalidate" action="/cfr-reference" accept-charset="UTF-8" method="get">
      <input label="false" value="current" autocomplete="off" type="hidden" name="cfr[date]" id="cfr_date" />
      <input value="{&quot;title&quot;:&quot;21&quot;,&quot;chapter&quot;:&quot;I&quot;,&quot;subchapter&quot;:&quot;F&quot;,&quot;part&quot;:&quot;606&quot;}" autocomplete="off" type="hidden" name="cfr[prior_hierarchy]" id="cfr_prior_hierarchy" />
      <input data-autocomplete-target="hidden" autocomplete="off" type="hidden" name="cfr[suggestion_id]" id="cfr_suggestion_id" />

      <div class="input-group input-group-lg">
        <input type="text" class="form-control string optional"
          data-action="focus->suggestions#modal"
          placeholder="Enter a search term or CFR reference (eg. fishing or 1 CFR 1.1)"
          type="text"
          data-suggestions-target="nonModalInput"
          name="cfr[reference]"
          id="suggestion">
        <span class="input-group-btn"
          data-action="click->suggestions#go">

          <button class="btn btn-optional" type="button"
            data-suggestions-target="nonModalSearchIcon"
            data-action="click->suggestions#go">
              <span class="icon-ecfr icon-ecfr-search "></span>
          </button>
        </span>
      </div>
</form>  </div>
</div>

          



<div class='row'>
  <div class="col-xs-12 col-md-12 no-padding">
    <div class='cfr-ref-wrapper'>
  <div data-controller="placeholder">
    <form class="simple_form go-to-cfr-reference" novalidate="novalidate" action="/cfr-reference" accept-charset="UTF-8" method="get">

      <div class="input-group input-group-lg">
        <input type="text" class="form-control string optional"
          data-action="focus->placeholder#suggestions"
          placeholder="Enter a search term or CFR reference (eg. fishing or 1 CFR 1.1)"
          type="text"
          data-suggestions-target="nonModalInput"
          name="cfr[reference]"
          id="suggestion">
        <span class="input-group-btn"
          data-action="click->placeholder#suggestions">

          <button class="btn btn-optional" type="button"
            data-suggestions-target="nonModalSearchIcon"
            data-action="click->placeholder#suggestions">
              <span class="icon-ecfr icon-ecfr-search "></span>
          </button>
        </span>
      </div>
</form>  </div>
</div>

  </div>
</div>

<div class="row breadcrumbs-wrapper ">
  <div class="col-xs-12 col-md-12 breadcrumb-nav" data-hierarchy="{&quot;title&quot;:&quot;21&quot;,&quot;chapter&quot;:&quot;I&quot;,&quot;subchapter&quot;:&quot;F&quot;,&quot;part&quot;:&quot;606&quot;}" data-filtered-search-enabled="true">
    <div class='row'>
      <div class="col-xs-12 col-md-9">
        <ol>
    <li class="">
        <a class="breadcrumb-link" data-toggle="tooltip" data-placement="top" data-title="View Table of Contents for Title 21—Food and Drugs" href="/current/title-21">Title 21 <span class="print-only breadcrumbs-title" data-hierarchy="{'title':'21'}">—Food and Drugs</span></a>
    </li>
    <li class="">
        <a class="breadcrumb-link" data-toggle="tooltip" data-placement="top" data-title="View Table of Contents for  Chapter I—Food and Drug Administration, Department of Health and Human Services" href="/current/title-21/chapter-I"> Chapter I <span class="print-only breadcrumbs-title" data-hierarchy="{'title':'21','chapter':'I'}">—Food and Drug Administration, Department of Health and Human Services</span></a>
    </li>
    <li class="">
        <a class="breadcrumb-link" data-toggle="tooltip" data-placement="top" data-title="View Table of Contents for Subchapter F—Biologics" href="/current/title-21/chapter-I/subchapter-F">Subchapter F <span class="print-only breadcrumbs-title" data-hierarchy="{'title':'21','chapter':'I','subchapter':'F'}">—Biologics</span></a>
    </li>
    <li class="breadcrumb-current">
        Part 606

    </li>
</ol>

      </div>

      <div class="col-xs-12 col-md-3 text-right">
        <ul class="prev-next-breadcrumb-nav">
  <li>
      <a id="previous-content-link" data-title="Part 601—Licensing" data-html="true" href="/current/title-21/chapter-I/subchapter-F/part-601">Previous</a>
  </li>

  <li>
      <a id="next-content-link" data-title="Part 607—Establishment Registration and Product Listing for Manufacturers of Human Blood and Blood Products and Licensed Devices" data-html="true" href="/current/title-21/chapter-I/subchapter-F/part-607">Next</a>
  </li>

  <li id="breadcrumb-back-to-top">
    <a data-title="Back to Top" data-turbo="false" href="#page-top">Top</a>
  </li>
</ul>

      </div>
    </div>
</div></div>


<div class="row ecfr-content-wrapper">
  <div class="col-xs-12 col-md-12 ecfr-content with-utility-bar">
    <div class="row">
      <div class="col-xs-3 col-sm-2 content-nav-wrapper content-nav-wrapper-wide">
        
<ul class="content-nav text-center dropdown drop-enhanced ui sticky">
  <li class="button">
    <span role="button" arial-label="compress content nav" class="icon-ecfr icon-ecfr-previous-media content-nav-compress-toggle"></span>
  </li>

  

<li class="enhanced " id="utility-nav-toc" tabindex="0"><span role="button" aria-label="Table of Contents" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Table of Contents" class="icon-ecfr icon-ecfr-book "></span><span class="content-nav-label " role="button">Table of Contents</span><div class="box box-enhanced box-enhanced-toc box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Table of Contents</h6></div></div><div class="content-block ">      <table class="table-of-contents root">
        <tr class="part  toggler-active"><td class="toc-label " colspan="1"><span data-toggle="{&quot;toggleTargetContext&quot;:&quot;grandparent&quot;}" class="icon-ecfr icon-ecfr-menu-arrow toggle"></span><span class="toc-text-secondary" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Part 606&lt;/span&gt;">Part 606</span></td><td class="description" colspan="1"><span class="text-toc-secondary" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;Part 606&lt;/span&gt;"><a data-turbo="false" href="#part-606">Current Good Manufacturing Practice for Blood and Blood Components</a></span></td><td class="section-identifiers"><span class="toc-range" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Part 606&lt;/span&gt;"><a data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;606.3 – 606.171&lt;/span&gt;" href="/current/title-21/chapter-I/subchapter-F/part-606?toc=1">606.3 – 606.171</a></span></td></tr><tr class="group"><td colspan="3"><table class="table-of-contents"><tr class="subpart  toggler-active"><td class="toc-label " colspan="1"><span data-toggle="{&quot;toggleTargetContext&quot;:&quot;grandparent&quot;}" class="icon-ecfr icon-ecfr-menu-arrow toggle"></span><span class="toc-text-secondary" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart A&lt;/span&gt;">Subpart A</span></td><td class="description" colspan="1"><span class="text-toc-secondary" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart A&lt;/span&gt;"><a data-turbo="false" href="#subpart-A">General Provisions</a></span></td><td class="section-identifiers"><span class="toc-range" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart A&lt;/span&gt;"><a data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;606.3&lt;/span&gt;" href="/current/title-21/chapter-I/subchapter-F/part-606/subpart-A?toc=1">606.3</a></span></td></tr><tr class="group"><td colspan="3"><table class="table-of-contents"><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.3&lt;/span&gt;">§ 606.3</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.3&lt;/span&gt;"><a data-turbo="false" href="#606.3">Definitions.</a></span></td></tr></table></td></tr><tr class="subpart  toggler-active"><td class="toc-label " colspan="1"><span data-toggle="{&quot;toggleTargetContext&quot;:&quot;grandparent&quot;}" class="icon-ecfr icon-ecfr-menu-arrow toggle"></span><span class="toc-text-secondary" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart B&lt;/span&gt;">Subpart B</span></td><td class="description" colspan="1"><span class="text-toc-secondary" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart B&lt;/span&gt;"><a data-turbo="false" href="#subpart-B">Organization and Personnel</a></span></td><td class="section-identifiers"><span class="toc-range" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart B&lt;/span&gt;"><a data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;606.20&lt;/span&gt;" href="/current/title-21/chapter-I/subchapter-F/part-606/subpart-B?toc=1">606.20</a></span></td></tr><tr class="group"><td colspan="3"><table class="table-of-contents"><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.20&lt;/span&gt;">§ 606.20</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.20&lt;/span&gt;"><a data-turbo="false" href="#606.20">Personnel.</a></span></td></tr></table></td></tr><tr class="subpart  toggler-active"><td class="toc-label " colspan="1"><span data-toggle="{&quot;toggleTargetContext&quot;:&quot;grandparent&quot;}" class="icon-ecfr icon-ecfr-menu-arrow toggle"></span><span class="toc-text-secondary" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart C&lt;/span&gt;">Subpart C</span></td><td class="description" colspan="1"><span class="text-toc-secondary" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart C&lt;/span&gt;"><a data-turbo="false" href="#subpart-C">Plant and Facilities</a></span></td><td class="section-identifiers"><span class="toc-range" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart C&lt;/span&gt;"><a data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;606.40&lt;/span&gt;" href="/current/title-21/chapter-I/subchapter-F/part-606/subpart-C?toc=1">606.40</a></span></td></tr><tr class="group"><td colspan="3"><table class="table-of-contents"><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.40&lt;/span&gt;">§ 606.40</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.40&lt;/span&gt;"><a data-turbo="false" href="#606.40">Facilities.</a></span></td></tr></table></td></tr><tr class="subpart  toggler-active"><td class="toc-label " colspan="1"><span data-toggle="{&quot;toggleTargetContext&quot;:&quot;grandparent&quot;}" class="icon-ecfr icon-ecfr-menu-arrow toggle"></span><span class="toc-text-secondary" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart D&lt;/span&gt;">Subpart D</span></td><td class="description" colspan="1"><span class="text-toc-secondary" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart D&lt;/span&gt;"><a data-turbo="false" href="#subpart-D">Equipment</a></span></td><td class="section-identifiers"><span class="toc-range" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart D&lt;/span&gt;"><a data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;606.60 – 606.65&lt;/span&gt;" href="/current/title-21/chapter-I/subchapter-F/part-606/subpart-D?toc=1">606.60 – 606.65</a></span></td></tr><tr class="group"><td colspan="3"><table class="table-of-contents"><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.60&lt;/span&gt;">§ 606.60</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.60&lt;/span&gt;"><a data-turbo="false" href="#606.60">Equipment.</a></span></td></tr><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.65&lt;/span&gt;">§ 606.65</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.65&lt;/span&gt;"><a data-turbo="false" href="#606.65">Supplies and reagents.</a></span></td></tr></table></td></tr><tr class="reserved subpart toc-leaf-node "><td colspan="3"><span class="description">Subpart E [Reserved]</span></td></tr><tr class="subpart  toggler-active"><td class="toc-label " colspan="1"><span data-toggle="{&quot;toggleTargetContext&quot;:&quot;grandparent&quot;}" class="icon-ecfr icon-ecfr-menu-arrow toggle"></span><span class="toc-text-secondary" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart F&lt;/span&gt;">Subpart F</span></td><td class="description" colspan="1"><span class="text-toc-secondary" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart F&lt;/span&gt;"><a data-turbo="false" href="#subpart-F">Production and Process Controls</a></span></td><td class="section-identifiers"><span class="toc-range" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart F&lt;/span&gt;"><a data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;606.100 – 606.110&lt;/span&gt;" href="/current/title-21/chapter-I/subchapter-F/part-606/subpart-F?toc=1">606.100 – 606.110</a></span></td></tr><tr class="group"><td colspan="3"><table class="table-of-contents"><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.100&lt;/span&gt;">§ 606.100</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.100&lt;/span&gt;"><a data-turbo="false" href="#606.100">Standard operating procedures.</a></span></td></tr><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.110&lt;/span&gt;">§ 606.110</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.110&lt;/span&gt;"><a data-turbo="false" href="#606.110">Plateletpheresis, leukapheresis, and plasmapheresis.</a></span></td></tr></table></td></tr><tr class="subpart  toggler-active"><td class="toc-label " colspan="1"><span data-toggle="{&quot;toggleTargetContext&quot;:&quot;grandparent&quot;}" class="icon-ecfr icon-ecfr-menu-arrow toggle"></span><span class="toc-text-secondary" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart G&lt;/span&gt;">Subpart G</span></td><td class="description" colspan="1"><span class="text-toc-secondary" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart G&lt;/span&gt;"><a data-turbo="false" href="#subpart-G">Additional Labeling Standards for Blood and Blood Components</a></span></td><td class="section-identifiers"><span class="toc-range" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart G&lt;/span&gt;"><a data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;606.120 – 606.122&lt;/span&gt;" href="/current/title-21/chapter-I/subchapter-F/part-606/subpart-G?toc=1">606.120 – 606.122</a></span></td></tr><tr class="group"><td colspan="3"><table class="table-of-contents"><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.120&lt;/span&gt;">§ 606.120</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.120&lt;/span&gt;"><a data-turbo="false" href="#606.120">Labeling, general requirements.</a></span></td></tr><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.121&lt;/span&gt;">§ 606.121</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.121&lt;/span&gt;"><a data-turbo="false" href="#606.121">Container label.</a></span></td></tr><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.122&lt;/span&gt;">§ 606.122</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.122&lt;/span&gt;"><a data-turbo="false" href="#606.122">Circular of information.</a></span></td></tr></table></td></tr><tr class="subpart  toggler-active"><td class="toc-label " colspan="1"><span data-toggle="{&quot;toggleTargetContext&quot;:&quot;grandparent&quot;}" class="icon-ecfr icon-ecfr-menu-arrow toggle"></span><span class="toc-text-secondary" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart H&lt;/span&gt;">Subpart H</span></td><td class="description" colspan="1"><span class="text-toc-secondary" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart H&lt;/span&gt;"><a data-turbo="false" href="#subpart-H">Laboratory Controls</a></span></td><td class="section-identifiers"><span class="toc-range" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart H&lt;/span&gt;"><a data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;606.140 – 606.151&lt;/span&gt;" href="/current/title-21/chapter-I/subchapter-F/part-606/subpart-H?toc=1">606.140 – 606.151</a></span></td></tr><tr class="group"><td colspan="3"><table class="table-of-contents"><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.140&lt;/span&gt;">§ 606.140</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.140&lt;/span&gt;"><a data-turbo="false" href="#606.140">Laboratory controls.</a></span></td></tr><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.145&lt;/span&gt;">§ 606.145</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.145&lt;/span&gt;"><a data-turbo="false" href="#606.145">Control of bacterial contamination of platelets.</a></span></td></tr><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.151&lt;/span&gt;">§ 606.151</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.151&lt;/span&gt;"><a data-turbo="false" href="#606.151">Compatibility testing.</a></span></td></tr></table></td></tr><tr class="subpart  toggler-active"><td class="toc-label " colspan="1"><span data-toggle="{&quot;toggleTargetContext&quot;:&quot;grandparent&quot;}" class="icon-ecfr icon-ecfr-menu-arrow toggle"></span><span class="toc-text-secondary" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart I&lt;/span&gt;">Subpart I</span></td><td class="description" colspan="1"><span class="text-toc-secondary" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart I&lt;/span&gt;"><a data-turbo="false" href="#subpart-I">Records and Reports</a></span></td><td class="section-identifiers"><span class="toc-range" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;Subpart I&lt;/span&gt;"><a data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;606.160 – 606.171&lt;/span&gt;" href="/current/title-21/chapter-I/subchapter-F/part-606/subpart-I?toc=1">606.160 – 606.171</a></span></td></tr><tr class="group"><td colspan="3"><table class="table-of-contents"><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.160&lt;/span&gt;">§ 606.160</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.160&lt;/span&gt;"><a data-turbo="false" href="#606.160">Records.</a></span></td></tr><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.165&lt;/span&gt;">§ 606.165</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.165&lt;/span&gt;"><a data-turbo="false" href="#606.165">Distribution and receipt; procedures and records.</a></span></td></tr><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.170&lt;/span&gt;">§ 606.170</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.170&lt;/span&gt;"><a data-turbo="false" href="#606.170">Adverse reaction file.</a></span></td></tr><tr class="section  toggler-active"><td class="toc-label " colspan="1"><span class="toc-wrapper" data-toggle="tooltip" data-placement="top" data-title="View Text of &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.171&lt;/span&gt;">§ 606.171</span></td><td class="description" colspan="2"><span class="text-wrapper" data-toggle="tooltip" data-placement="left" data-title="View Table of Contents for &lt;span class=&#39;avoid-wrap&#39;&gt;§ 606.171&lt;/span&gt;"><a data-turbo="false" href="#606.171">Reporting of product deviations by licensed manufacturers, unlicensed registered blood establishments, and transfusion services.</a></span></td></tr></table></td></tr></table></td></tr>
      </table>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Table of Contents</h6></div></div></li>

  
<li class="enhanced " id="utility-nav-details" tabindex="0"><span role="button" aria-label="Details" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Details" class="icon-ecfr icon-ecfr-book-alt-2 "></span><span class="content-nav-label " role="button">Details</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Details</h6></div></div><div class="content-block ">    <dl class="">
      <dt>URL</dt>
      <dd>
        https://www.ecfr.gov/current/title-21/part-606
        <span data-toggle="tooltip" data-title="Copy to Clipboard" class="svg-tooltip copy-to-clipboard" data-title-copied="Copied to Clipboard" data-copy-text="https://www.ecfr.gov/current/title-21/part-606"><svg class="ecfr-svg-icon ecfr-svg-icon-content-copy "><use xlink:href="/assets/ecfr-icons-c08c495b1eda093da23b5b159c24927a91aa7c13df40f52ca7d30476904de0ea.svg#ecfr-svg-icon-content-copy"></use></svg></span>
      </dd>

        <dt>Citation</dt>
        <dd>
          21 CFR Part 606
          <span data-toggle="tooltip" data-title="Copy to Clipboard" class="svg-tooltip copy-to-clipboard" data-title-copied="Copied to Clipboard" data-copy-text="21 CFR Part 606"><svg class="ecfr-svg-icon ecfr-svg-icon-content-copy "><use xlink:href="/assets/ecfr-icons-c08c495b1eda093da23b5b159c24927a91aa7c13df40f52ca7d30476904de0ea.svg#ecfr-svg-icon-content-copy"></use></svg></span>
        </dd>



        <dt>
          Agency
          <span data-toggle="tooltip" data-title="The agency currently associated with this eCFR content. Click for more details." class="svg-tooltip clickable" data-url="/reader-aids/using-ecfr/agency-references#details_sidebar" data-container="dl"><svg class="ecfr-svg-icon ecfr-svg-icon-info-circle "><use xlink:href="/assets/ecfr-icons-c08c495b1eda093da23b5b159c24927a91aa7c13df40f52ca7d30476904de0ea.svg#ecfr-svg-icon-info-circle"></use></svg></span>
        </dt>
          <dd data-issuing-agency=food-and-drug-administration>Food and Drug Administration, Department of Health and Human Services</dd>
    </dl>

    <hr>

    <div id="source-and-authority">
        <div class="additional-source-and-authority">
      <div class="level">
        <a href="/current/title-21/part-606" class="cfr reference">Part 606</a>
        <div class="details" data-hierarchy="{:title=&gt;&quot;21&quot;, :chapter=&gt;&quot;I&quot;, :subchapter=&gt;&quot;F&quot;, :part=&gt;&quot;606&quot;}" data-current="true">
            <div class="authority">
              <h4 class="inline-header">Authority:</h4>
              <p class="inline-paragraph">
                <a href="https://www.govinfo.gov/link/uscode/21/321" class="usc external" target="_blank" rel="noopener noreferrer">21 U.S.C. 321</a>, <a href="https://www.govinfo.gov/link/uscode/21/331" class="usc external" target="_blank" rel="noopener noreferrer">331</a>, <a href="https://www.govinfo.gov/link/uscode/21/351" class="usc external" target="_blank" rel="noopener noreferrer">351</a>, <a href="https://www.govinfo.gov/link/uscode/21/352" class="usc external" target="_blank" rel="noopener noreferrer">352</a>, <a href="https://www.govinfo.gov/link/uscode/21/355" class="usc external" target="_blank" rel="noopener noreferrer">355</a>, <a href="https://www.govinfo.gov/link/uscode/21/360" class="usc external" target="_blank" rel="noopener noreferrer">360</a>, <a href="https://www.govinfo.gov/link/uscode/21/360j" class="usc external" target="_blank" rel="noopener noreferrer">360j</a>, <a href="https://www.govinfo.gov/link/uscode/21/371" class="usc external" target="_blank" rel="noopener noreferrer">371</a>, <a href="https://www.govinfo.gov/link/uscode/21/374" class="usc external" target="_blank" rel="noopener noreferrer">374</a>; <a href="https://www.govinfo.gov/link/uscode/42/216" class="usc external" target="_blank" rel="noopener noreferrer">42 U.S.C. 216</a>, <a href="https://www.govinfo.gov/link/uscode/42/262" class="usc external" target="_blank" rel="noopener noreferrer">262</a>, <a href="https://www.govinfo.gov/link/uscode/42/263a" class="usc external" target="_blank" rel="noopener noreferrer">263a</a>, <a href="https://www.govinfo.gov/link/uscode/42/264" class="usc external" target="_blank" rel="noopener noreferrer">264</a>.


              </p>
            </div>
            <div class="source">
              <h4 class="inline-header">Source:</h4>
              <p class="inline-paragraph">
                <a href="https://www.federalregister.gov/citation/40-FR-53532" class="fr-reference" data-reference="40 FR 53532">40 FR 53532</a>, Nov. 18, 1975, unless otherwise noted.


              </p>
            </div>
        </div>
      </div>
  </div>

    </div>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Details</h6></div></div></li>

  
<li class="enhanced " id="" tabindex="0"><span role="button" aria-label="Print/PDF" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Print/PDF" class="icon-ecfr icon-ecfr-print "></span><span class="content-nav-label " role="button">Print/PDF</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Print</h6></div></div><div class="content-block ">      <p>
        <a class="generate-pdf" data-original-text="Generate PDF <small class=&quot;text-warning&quot;>(approximately 10+ pages)</small>" href="#">Generate PDF <small class="text-warning">(approximately 10+ pages)</small></a>

        <span class="pdf-spinner" style="display:none;">
          <span class="spinner"></span>
        </span>
      </p>
      <p>
        This content is from the eCFR and may include recent changes applied to the CFR.
        The official, published CFR, is updated annually and available below under
        "Published Edition". You can learn more about the process
        <a href="https://www.govinfo.gov/help/cfr#about">here</a>.
      </p>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Print</h6></div></div></li>

  
<li class="enhanced " id="" tabindex="0"><span role="button" aria-label="Display Options" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Display Options" class="icon-ecfr icon-ecfr-doc-generic "></span><span class="content-nav-label " role="button">Display Options</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Display Options</h6></div></div><div class="content-block ">    <turbo-frame id="side_display" src="/display/current/title-21/chapter-I/subchapter-F/part-606" loading="lazy">
      <span class="timeline-spinner">
        <span class="spinner"></span>
      </span>
    </turbo-frame>  
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Display Options</h6></div></div></li>

  
<li class="enhanced utility-nav-subscribe" id="utility-nav-subscribe" tabindex="0"><span role="button" aria-label="Subscribe" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Subscribe" class="icon-ecfr icon-ecfr-message "></span><span class="content-nav-label " role="button">Subscribe</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Subscribe</h6></div></div><div class="content-block ">    <p><strong>Subscribe to:</strong> 21 CFR Part 606</p>

    <div class="subscription-option">
      <form class="simple_form form-horizontal subscribe" id="new_subscription" data-turbo="false" novalidate="novalidate" action="/my/subscriptions" accept-charset="UTF-8" method="post">
            <div class="form-group hidden subscription_title"><input class="form-control hidden hierarchy-input" value="21" name="search[hierarchy][title]" autocomplete="off" type="hidden" id="subscription_title" /></div>
            <div class="form-group hidden subscription_chapter"><input class="form-control hidden hierarchy-input" value="I" name="search[hierarchy][chapter]" autocomplete="off" type="hidden" id="subscription_chapter" /></div>
            <div class="form-group hidden subscription_subchapter"><input class="form-control hidden hierarchy-input" value="F" name="search[hierarchy][subchapter]" autocomplete="off" type="hidden" id="subscription_subchapter" /></div>
            <div class="form-group hidden subscription_part"><input class="form-control hidden hierarchy-input" value="606" name="search[hierarchy][part]" autocomplete="off" type="hidden" id="subscription_part" /></div>

        <div class="subscription-option">
          <span class="icon-ecfr icon-ecfr-message "></span><label class='email-label'>Via Email:</label>
          <input type="submit" name="commit" value="Subscribe" class="btn-as-link" data-disable-with="Subscribe" />
        </div>

        <!-- <div class="subscription-option"> -->
          <!-- <label class='rss-label'>Via RSS:</label> -->

        <!-- </div> -->
</form>    </div>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Subscribe</h6></div></div></li>

  <li class="divider"></li>

    
<li class="enhanced " id="utility-nav-timeline" tabindex="0"><span role="button" aria-label="Timeline" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Timeline" class="icon-ecfr icon-ecfr-hourglass "></span><span class="content-nav-label " role="button">Timeline</span><div class="box box-enhanced box-enhanced-timeline box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Timeline</h6></div></div><div class="content-block ">
        <turbo-frame data-controller="timeline" id="side_timeline" target="_top">
      <p>
        No changes found for this content after 1/03/2017.
      </p>
</turbo-frame>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Timeline</h6></div></div></li>

  
<li class="enhanced " id="utility-nav-go-to-date" tabindex="0"><span role="button" aria-label="Go to Date" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Go to Date" class="icon-ecfr icon-ecfr-calendar-alt "></span><span class="content-nav-label " role="button">Go to Date</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Go to Date</h6></div></div><div class="content-block ">    <form class="simple_form form-horizontal go-to-date" id="go-to-date-form" autocomplete="off" novalidate="novalidate" action="#" accept-charset="UTF-8" method="get">

      <div class="form-group bootstrap_datepicker optional go_to_date_date"><label class="control-label bootstrap_datepicker optional" for="go_to_date_date">Date</label><div class='input-group'>
<input class="form-control bootstrap_datepicker optional bootstrap-datepicker" data-date-start-date="1/03/2017" data-date-force-parse="false" data-date-assume-nearby-year="true" data-date-format="mm/dd/yyyy" data-date-autoclose="true" data-provide="datepicker" type="text" name="go_to_date[date_box]" id="go_to_date_date_box" />
<span class='input-group-addon calendar-btn'><span class='glyphicon glyphicon-calendar'></span></span>
</div>
<input class="form-control bootstrap_datepicker optional" data-date-start-date="1/03/2017" data-date-force-parse="false" data-date-assume-nearby-year="true" data-date-format="mm/dd/yyyy" data-date-autoclose="true" data-provide="datepicker" id="date_hidden" value="" autocomplete="off" type="hidden" name="go_to_date[date]" />
</div>

      <input type="submit" name="commit" value="Go to date" class="btn btn-default btn btn-primary-alt btn-medium" data-disable-with="Go to date" />
</form>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Go to Date</h6></div></div></li>

  

<li class="enhanced " id="utility-nav-compare" tabindex="0"><span role="button" aria-label="Compare Dates" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Compare Dates" class="icon-ecfr icon-ecfr-forking "></span><span class="content-nav-label " role="button">Compare Dates</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Compare Dates</h6></div></div><div class="content-block ">      <form class="simple_form form-horizontal compare-content" id="new_compare" autocomplete="off" novalidate="novalidate" action="/compare" accept-charset="UTF-8" method="post">

        <div class="form-group bootstrap_datepicker optional compare_from"><label class="control-label bootstrap_datepicker optional" for="compare_from">Compare</label><div class='input-group'>
<input class="form-control bootstrap_datepicker optional bootstrap-datepicker" data-date-start-date="1/03/2017" data-date-force-parse="false" data-date-assume-nearby-year="true" data-date-format="mm/dd/yyyy" data-date-autoclose="true" data-provide="datepicker" type="text" name="compare[from_box]" id="compare_from_box" />
<span class='input-group-addon calendar-btn'><span class='glyphicon glyphicon-calendar'></span></span>
</div>
<input class="form-control bootstrap_datepicker optional" data-date-start-date="1/03/2017" data-date-force-parse="false" data-date-assume-nearby-year="true" data-date-format="mm/dd/yyyy" data-date-autoclose="true" data-provide="datepicker" id="from_hidden" value="" autocomplete="off" type="hidden" name="compare[from]" />
</div>

        <div class="form-group bootstrap_datepicker optional compare_to"><label class="control-label bootstrap_datepicker optional" for="compare_to">to</label><div class='input-group'>
<input class="form-control bootstrap_datepicker optional bootstrap-datepicker" data-date-start-date="1/03/2017" data-date-force-parse="false" data-date-assume-nearby-year="true" data-date-format="mm/dd/yyyy" data-date-autoclose="true" data-provide="datepicker" type="text" value="04/09/2025" name="compare[to_box]" id="compare_to_box" />
<span class='input-group-addon calendar-btn'><span class='glyphicon glyphicon-calendar'></span></span>
</div>
<input class="form-control bootstrap_datepicker optional" data-date-start-date="1/03/2017" data-date-force-parse="false" data-date-assume-nearby-year="true" data-date-format="mm/dd/yyyy" data-date-autoclose="true" data-provide="datepicker" id="to_hidden" value="2025-04-09" autocomplete="off" type="hidden" name="compare[to]" />
</div>

        <div class="form-group hidden compare_hierarchy"><input class="form-control hidden" autocomplete="off" type="hidden" value="{&quot;title&quot;:&quot;21&quot;,&quot;chapter&quot;:&quot;I&quot;,&quot;subchapter&quot;:&quot;F&quot;,&quot;part&quot;:&quot;606&quot;,&quot;complete&quot;:true}" name="compare[hierarchy]" id="compare_hierarchy" /></div>
        <div class="form-group hidden compare_view_mode"><input class="form-control hidden" autocomplete="off" type="hidden" name="compare[view_mode]" id="compare_view_mode" /></div>

        <input type="submit" name="commit" value="Compare Dates" class="btn btn-default btn btn-primary-alt btn-medium" data-disable-with="Compare Dates" />
</form>
      <form class="simple_form compare-style-choices" id="new_compare_style_choices" novalidate="novalidate" action="#" accept-charset="UTF-8" method="get">
        <div class="form-group radio_buttons optional compare_style_choices_diff_color"><label class="control-label radio_buttons optional">Show changes as:</label><span class="radio"><label for="compare_style_choices_diff_color_rg-diff"><input class="radio_buttons optional" type="radio" value="rg-diff" checked="checked" name="compare_style_choices[diff_color]" id="compare_style_choices_diff_color_rg-diff" />red/green</label></span><span class="radio"><label for="compare_style_choices_diff_color_po-diff"><input class="radio_buttons optional" type="radio" value="po-diff" name="compare_style_choices[diff_color]" id="compare_style_choices_diff_color_po-diff" />purple/orange</label></span></div>

        <div class="form-group radio_buttons optional compare_style_choices_strikethrough"><label class="control-label radio_buttons optional">Show strike-through for removed content</label><span class="radio"><label for="compare_style_choices_strikethrough_true"><input class="radio_buttons optional" type="radio" value="true" checked="checked" name="compare_style_choices[strikethrough]" id="compare_style_choices_strikethrough_true" />yes</label></span><span class="radio"><label for="compare_style_choices_strikethrough_false"><input class="radio_buttons optional" readonly="readonly" type="radio" value="false" name="compare_style_choices[strikethrough]" id="compare_style_choices_strikethrough_false" />no</label></span></div>
</form></div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Compare Dates</h6></div></div></li>

  <li class="divider"></li>

  
<li class="enhanced published-edition" id="" tabindex="0"><span role="button" aria-label="Published Edition" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Published Edition" class="icon-ecfr icon-ecfr-doc-pdf "></span><span class="content-nav-label " role="button">Published Edition</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Published Edition</h6></div></div><div class="content-block ">    <p>
      View the most recent official publication:
    </p>

    <ul class="list with-bullets enhanced">
        <li>
          <a data-turbo="false" href="https://www.govinfo.gov/app/collection/cfr/2025">View Title 21 on govinfo.gov</a>
        </li>
        <li>
          <a data-turbo="false" href="https://www.govinfo.gov/link/cfr/21/606?link-type=pdf&amp;year=mostrecent">View the PDF for 21 CFR Part 606</a>
        </li>
    </ul>

    <p>
      These links go to the official, published CFR, which is updated annually. As a
      result, it may not include the most recent changes applied to the CFR.
      <a href="https://www.govinfo.gov/help/cfr#about">Learn more</a>.
    </p>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Published Edition</h6></div></div></li>

  <li class="divider"></li>

  
<li class="enhanced developer-tools" id="" tabindex="0"><span role="button" aria-label="Developer Tools" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Developer Tools" class="icon-ecfr icon-ecfr-console "></span><span class="content-nav-label " role="button">Developer Tools</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Developer Tools</h6></div></div><div class="content-block ">
      <turbo-frame id="side_developer" src="/developer/current/title-21/chapter-I/subchapter-F/part-606" loading="lazy">
        <span class="timeline-spinner">
          <span class="spinner"></span>
        </span>
        <br/><br/>
      </turbo-frame>

    <p>
      Information and documentation can be found in our
      <a href="/reader-aids/ecfr-developer-resources">developer resources</a>.
    </p>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Developer Tools</h6></div></div></li>
</ul>

      </div>

      <div class="col-xs-9 col-sm-10 content-col">
        <div class="box box-published no-print-header compare-settings"><div class="seal-block seal-block-header"><div class="seal-content"><h6>eCFR Content</h6><div class="row seal-meta"><div class="seal-desc col-md-12 col-xs-12"><p><p>The <em>Code of Federal Regulations</em> (CFR) is the official legal print publication containing the codification of the general and permanent rules published in the <em>Federal Register</em> by the departments and agencies of the Federal Government. The Electronic Code of Federal Regulations (eCFR) is a continuously updated online version of the CFR. It is not an official legal edition of the CFR.</p> <p><a href='/reader-aids/understanding-the-ecfr/what-is-the-ecfr'>Learn more</a> about the eCFR, its status, and the editorial process.<p></p></div></div></div></div><div class="content-block ">
            <div class="box box-enhanced slim toc-link no-footer"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content</h6></div></div><div class="content-block ">
              <span class="icon-ecfr icon-ecfr-book "></span> View
              <a id="toc-utility-nav-link" href="">table of contents</a>
              for this page.
</div><div class="seal-block seal-block-footer"></div></div>
          
<div class="part" id="part-606"><h1 data-hierarchy-metadata="{&quot;path&quot;:&quot;/current/title-21/part-606&quot;,&quot;citation&quot;:&quot;21 CFR Part 606&quot;}">PART 606—CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS
</h1>

<div class="authority"><h4 class="inline-header">Authority:</h4><p class="inline-paragraph"><a href="https://www.govinfo.gov/link/uscode/21/321" class="usc external" target="_blank" rel="noopener noreferrer">21 U.S.C. 321</a>, <a href="https://www.govinfo.gov/link/uscode/21/331" class="usc external" target="_blank" rel="noopener noreferrer">331</a>, <a href="https://www.govinfo.gov/link/uscode/21/351" class="usc external" target="_blank" rel="noopener noreferrer">351</a>, <a href="https://www.govinfo.gov/link/uscode/21/352" class="usc external" target="_blank" rel="noopener noreferrer">352</a>, <a href="https://www.govinfo.gov/link/uscode/21/355" class="usc external" target="_blank" rel="noopener noreferrer">355</a>, <a href="https://www.govinfo.gov/link/uscode/21/360" class="usc external" target="_blank" rel="noopener noreferrer">360</a>, <a href="https://www.govinfo.gov/link/uscode/21/360j" class="usc external" target="_blank" rel="noopener noreferrer">360j</a>, <a href="https://www.govinfo.gov/link/uscode/21/371" class="usc external" target="_blank" rel="noopener noreferrer">371</a>, <a href="https://www.govinfo.gov/link/uscode/21/374" class="usc external" target="_blank" rel="noopener noreferrer">374</a>; <a href="https://www.govinfo.gov/link/uscode/42/216" class="usc external" target="_blank" rel="noopener noreferrer">42 U.S.C. 216</a>, <a href="https://www.govinfo.gov/link/uscode/42/262" class="usc external" target="_blank" rel="noopener noreferrer">262</a>, <a href="https://www.govinfo.gov/link/uscode/42/263a" class="usc external" target="_blank" rel="noopener noreferrer">263a</a>, <a href="https://www.govinfo.gov/link/uscode/42/264" class="usc external" target="_blank" rel="noopener noreferrer">264</a>.
</p></div>

<div class="source"><h4 class="inline-header">Source:</h4><p class="inline-paragraph"><a href="https://www.federalregister.gov/citation/40-FR-53532" class="fr-reference" data-reference="40 FR 53532">40 FR 53532</a>, Nov. 18, 1975, unless otherwise noted.
</p></div>

<div class="subpart" id="subpart-A"><h2 data-hierarchy-metadata="{&quot;path&quot;:&quot;/current/title-21/part-606/subpart-A&quot;,&quot;citation&quot;:&quot;21 CFR Part 606 Subpart A&quot;}">Subpart A—General Provisions</h2>
<div class="section" id="606.3">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.3","citation":"21 CFR 606.3"}'>§ 606.3 Definitions.</h4>
<p>As used in this part:</p>
<div id="p-606.3(a)">
<p class="indent-1" data-title="606.3(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> <em class="paragraph-heading">Blood</em>  means a product that is a fluid containing dissolved and suspended elements which was collected from the vascular system of a human.</p>
</div>
<div id="p-606.3(b)">
<p class="indent-1" data-title="606.3(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> <em class="paragraph-heading">Unit</em>  means the volume of blood or one of its components in a suitable volume of anticoagulant obtained from a single collection of blood from one donor.</p>
</div>
<div id="p-606.3(c)">
<p class="indent-1" data-title="606.3(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> <em class="paragraph-heading">Blood component</em>  means a product containing a part of human blood separated by physical or mechanical means.</p>
</div>
<div id="p-606.3(d)">
<p class="indent-1" data-title="606.3(d)"><span class="paragraph-hierarchy"><span class="paren">(</span>d<span class="paren">)</span></span> <em class="paragraph-heading">Plasma for further manufacturing</em>  means that liquid portion of blood separated and used as material to prepare another product.</p>
</div>
<div id="p-606.3(e)">
<p class="indent-1" data-title="606.3(e)"><span class="paragraph-hierarchy"><span class="paren">(</span>e<span class="paren">)</span></span> <em class="paragraph-heading">Plasmapheresis</em>  means the procedure in which blood is removed from the donor, the plasma is separated from the formed elements and at least the red blood cells are returned to the donor.</p>
</div>
<div id="p-606.3(f)">
<p class="indent-1" data-title="606.3(f)"><span class="paragraph-hierarchy"><span class="paren">(</span>f<span class="paren">)</span></span> <em class="paragraph-heading">Plateletpheresis</em>  means the procedure in which blood is removed from a donor, a platelet concentrate is separated, and the remaining formed elements are returned to the donor along with a portion of the residual plasma.</p>
</div>
<div id="p-606.3(g)">
<p class="indent-1" data-title="606.3(g)"><span class="paragraph-hierarchy"><span class="paren">(</span>g<span class="paren">)</span></span> <em class="paragraph-heading">Leukapheresis</em>  means the procedure in which blood is removed from the donor, a leukocyte concentrate is separated, and the remaining formed elements and residual plasma are returned to the donor.</p>
</div>
<div id="p-606.3(h)">
<p class="indent-1" data-title="606.3(h)"><span class="paragraph-hierarchy"><span class="paren">(</span>h<span class="paren">)</span></span> <em class="paragraph-heading">Facilities</em>  means any area used for the collection, processing, compatibility testing, storage or distribution of blood and blood components.</p>
</div>
<div id="p-606.3(i)">
<p class="indent-1" data-title="606.3(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> <em class="paragraph-heading">Processing</em>  means any procedure employed after collection, and before or after compatibility testing of blood, and includes the identification of a unit of donor blood, the preparation of components from such unit of donor blood, serological testing, labeling and associated recordkeeping.</p>
</div>
<div id="p-606.3(j)">
<p class="indent-1" data-title="606.3(j)"><span class="paragraph-hierarchy"><span class="paren">(</span>j<span class="paren">)</span></span> <em class="paragraph-heading">Compatibility testing</em>  means the procedures performed to establish the matching of a donor's blood or blood components with that of a potential recipient.</p>
</div>
<div id="p-606.3(k)">
<p class="indent-1" data-title="606.3(k)"><span class="paragraph-hierarchy"><span class="paren">(</span>k<span class="paren">)</span></span> <em class="paragraph-heading">Distributed</em>  means:</p>
<div id="p-606.3(k)(1)">
<p class="indent-2" data-title="606.3(k)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> The blood or blood components have left the control of the licensed manufacturer, unlicensed registered blood establishment, or transfusion service; or</p>
</div>
<div id="p-606.3(k)(2)">
<p class="indent-2" data-title="606.3(k)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> The licensed manufacturer has provided Source Plasma or any other blood component for use in the manufacture of a licensed biological product.</p>
</div>
</div>
<div id="p-606.3(l)"><p class="indent-1" data-title="606.3(l)"><span class="paragraph-hierarchy"><span class="paren">(</span>l<span class="paren">)</span></span> <em class="paragraph-heading">Control</em>  means having responsibility for maintaining the continued safety, purity, and potency of the product and for compliance with applicable product and establishment standards, and for compliance with current good manufacturing practices.</p></div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/40-FR-53532" class="fr-reference" data-reference="40 FR 53532">40 FR 53532</a>, Nov. 18, 1975, as amended at <a href="https://www.federalregister.gov/citation/64-FR-45370" class="fr-reference" data-reference="64 FR 45370">64 FR 45370</a>, Aug. 19, 1999; <a href="https://www.federalregister.gov/citation/65-FR-66635" class="fr-reference" data-reference="65 FR 66635">65 FR 66635</a>, Nov. 7, 2000; <a href="https://www.federalregister.gov/citation/66-FR-1835" class="fr-reference" data-reference="66 FR 1835">66 FR 1835</a>, Jan. 10, 2001; <a href="https://www.federalregister.gov/citation/66-FR-40889" class="fr-reference" data-reference="66 FR 40889">66 FR 40889</a>, Aug. 6, 2001; <a href="https://www.federalregister.gov/citation/72-FR-45886" class="fr-reference" data-reference="72 FR 45886">72 FR 45886</a>, Aug. 16, 2007; <a href="https://www.federalregister.gov/citation/80-FR-29894" class="fr-reference" data-reference="80 FR 29894">80 FR 29894</a>, May 22, 2015]
</p>
</div>

</div>

<div class="subpart" id="subpart-B"><h2 data-hierarchy-metadata="{&quot;path&quot;:&quot;/current/title-21/part-606/subpart-B&quot;,&quot;citation&quot;:&quot;21 CFR Part 606 Subpart B&quot;}">Subpart B—Organization and Personnel</h2>
<div class="section" id="606.20">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.20","citation":"21 CFR 606.20"}'>§ 606.20 Personnel.</h4>
<div id="p-606.20(a)">
<p class="indent-1" data-title="606.20(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> [Reserved]</p>
</div>
<div id="p-606.20(b)">
<p class="indent-1" data-title="606.20(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> The personnel responsible for the collection, processing, compatibility testing, storage or distribution of blood or blood components shall be adequate in number, educational background, training and experience, including professional training as necessary, or combination thereof, to assure competent performance of their assigned functions, and to ensure that the final product has the safety, purity, potency, identity and effectiveness it purports or is represented to possess. All personnel shall have capabilities commensurate with their assigned functions, a thorough understanding of the procedures or control operations they perform, the necessary training or experience, and adequate information concerning the application of pertinent provisions of this part to their respective functions.</p>
</div>
<div id="p-606.20(c)"><p class="indent-1" data-title="606.20(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> Persons whose presence can adversely affect the safety and purity of the products shall be excluded from areas where the collection, processing, compatibility testing, storage or distribution of blood or blood components is conducted.</p></div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/40-FR-53532" class="fr-reference" data-reference="40 FR 53532">40 FR 53532</a>, Nov. 18, 1975, as amended at <a href="https://www.federalregister.gov/citation/49-FR-23833" class="fr-reference" data-reference="49 FR 23833">49 FR 23833</a>, June 8, 1984; <a href="https://www.federalregister.gov/citation/55-FR-11014" class="fr-reference" data-reference="55 FR 11014">55 FR 11014</a>, Mar. 26, 1990; <a href="https://www.federalregister.gov/citation/62-FR-53538" class="fr-reference" data-reference="62 FR 53538">62 FR 53538</a>, Oct. 15, 1997]
</p>
</div>

</div>

<div class="subpart" id="subpart-C"><h2 data-hierarchy-metadata="{&quot;path&quot;:&quot;/current/title-21/part-606/subpart-C&quot;,&quot;citation&quot;:&quot;21 CFR Part 606 Subpart C&quot;}">Subpart C—Plant and Facilities</h2>
<div class="section" id="606.40">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.40","citation":"21 CFR 606.40"}'>§ 606.40 Facilities.</h4>
<p>Facilities shall be maintained in a clean and orderly manner, and shall be of suitable size, construction and location to facilitate adequate cleaning, maintenance and proper operations. The facilities shall:</p>
<div id="p-606.40(a)">
<p class="indent-1" data-title="606.40(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> Provide adequate space for the following when applicable:</p>
<div id="p-606.40(a)(1)">
<p class="indent-2" data-title="606.40(a)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> Private and accurate examinations of individuals to determine their eligibility as blood donors.</p>
</div>
<div id="p-606.40(a)(2)">
<p class="indent-2" data-title="606.40(a)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> The withdrawal of blood from donors with minimal risk of contamination, or exposure to activities and equipment unrelated to blood collection.</p>
</div>
<div id="p-606.40(a)(3)">
<p class="indent-2" data-title="606.40(a)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> The storage of blood or blood components pending completion of tests.</p>
</div>
<div id="p-606.40(a)(4)">
<p class="indent-2" data-title="606.40(a)(4)"><span class="paragraph-hierarchy"><span class="paren">(</span>4<span class="paren">)</span></span> The quarantine storage of blood or blood components in a designated location pending repetition of those tests that initially gave questionable serological results.</p>
</div>
<div id="p-606.40(a)(5)">
<p class="indent-2" data-title="606.40(a)(5)"><span class="paragraph-hierarchy"><span class="paren">(</span>5<span class="paren">)</span></span> The storage of finished products prior to distribution.</p>
</div>
<div id="p-606.40(a)(6)">
<p class="indent-2" data-title="606.40(a)(6)"><span class="paragraph-hierarchy"><span class="paren">(</span>6<span class="paren">)</span></span> The quarantine storage, handling and disposition of products and reagents not suitable for use.</p>
</div>
<div id="p-606.40(a)(7)">
<p class="indent-2" data-title="606.40(a)(7)"><span class="paragraph-hierarchy"><span class="paren">(</span>7<span class="paren">)</span></span> The orderly collection, processing, compatibility testing, storage and distribution of blood and blood components to prevent contamination.</p>
</div>
<div id="p-606.40(a)(8)">
<p class="indent-2" data-title="606.40(a)(8)"><span class="paragraph-hierarchy"><span class="paren">(</span>8<span class="paren">)</span></span> The adequate and proper performance of all steps in plasmapheresis, plateletpheresis and leukapheresis procedures.</p>
</div>
<div id="p-606.40(a)(9)">
<p class="indent-2" data-title="606.40(a)(9)"><span class="paragraph-hierarchy"><span class="paren">(</span>9<span class="paren">)</span></span> The orderly conduction of all packaging, labeling and other finishing operations.</p>
</div>
</div>
<div id="p-606.40(b)">
<p class="indent-1" data-title="606.40(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> Provide adequate lighting, ventilation and screening of open windows and doors.</p>
</div>
<div id="p-606.40(c)">
<p class="indent-1" data-title="606.40(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> Provide adequate, clean, and convenient handwashing facilities for personnel, and adequate, clean, and convenient toilet facilities for donors and personnel. Drains shall be of adequate size and, where connected directly to a sewer, shall be equipped with traps to prevent back-siphonage.</p>
</div>
<div id="p-606.40(d)">
<p class="indent-1" data-title="606.40(d)"><span class="paragraph-hierarchy"><span class="paren">(</span>d<span class="paren">)</span></span> Provide for safe and sanitary disposal for the following:</p>
<div id="p-606.40(d)(1)">
<p class="indent-2" data-title="606.40(d)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> Trash and items used during the collection, processing and compatibility testing of blood and blood components.</p>
</div>
<div id="p-606.40(d)(2)"><p class="indent-2" data-title="606.40(d)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> Blood and blood components not suitable for use or distribution.</p></div>
</div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/40-FR-53532" class="fr-reference" data-reference="40 FR 53532">40 FR 53532</a>, Nov. 18, 1975, as amended at <a href="https://www.federalregister.gov/citation/80-FR-29895" class="fr-reference" data-reference="80 FR 29895">80 FR 29895</a>, May 22, 2015]
</p>
</div>

</div>

<div class="subpart" id="subpart-D"><h2 data-hierarchy-metadata="{&quot;path&quot;:&quot;/current/title-21/part-606/subpart-D&quot;,&quot;citation&quot;:&quot;21 CFR Part 606 Subpart D&quot;}">Subpart D—Equipment</h2>
<div class="section" id="606.60">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.60","citation":"21 CFR 606.60"}'>§ 606.60 Equipment.</h4>
<div id="p-606.60(a)">
<p class="indent-1" data-title="606.60(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> Equipment used in the collection, processing, compatibility testing, storage and distribution of blood and blood components shall be maintained in a clean and orderly manner and located so as to facilitate cleaning and maintenance. The equipment shall be observed, standardized and calibrated on a regularly scheduled basis as prescribed in the Standard Operating Procedures Manual and shall perform in the manner for which it was designed so as to assure compliance with the official requirements prescribed in this chapter for blood and blood products.</p>
</div>
<div id="p-606.60(b)">
<p class="indent-1" data-title="606.60(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> Equipment that shall be observed, standardized and calibrated with at least the following frequency, include but are not limited to:</p>
<div class="table-wrapper">
<div class="gpotbl_div"><table border="1" cellpadding="1" cellspacing="1" class="gpo_table" frame="void" width="100%">
<thead>
<tr>
<th class="center border-top-single border-bottom-single border-right-single">Equipment</th>
<th class="center border-top-single border-bottom-single border-right-single">Performance check</th>
<th class="center border-top-single border-bottom-single border-right-single">Frequency</th>
<th class="center border-top-single border-bottom-single">Frequency of calibration</th>
</tr>
</thead>
<tbody>
<tr>
<td class="left border-right-single">Temperature recorder</td>
<td class="left border-right-single">Compare against thermometer</td>
<td class="left border-right-single">Daily</td>
<td class="left">As necessary.</td>
</tr>
<tr>
<td class="left border-right-single">Refrigerated centrifuge</td>
<td class="left border-right-single">Observe speed and temperature</td>
<td class="left border-right-single">Each day of use</td>
<td class="left"> Do.</td>
</tr>
<tr>
<td class="left border-right-single">Hematocrit centrifuge</td>
<td class="left border-right-single"></td>
<td class="left border-right-single"></td>
<td class="left">Standardize before initial use, after repairs or adjustments, and annually. Timer every 3 mo.</td>
</tr>
<tr>
<td class="left border-right-single">General lab centrifuge</td>
<td class="left border-right-single"></td>
<td class="left border-right-single"></td>
<td class="left">Tachometer every 6 mo.</td>
</tr>
<tr>
<td class="left border-right-single">Automated blood-typing machine</td>
<td class="left border-right-single">Observe controls for correct results</td>
<td class="left border-right-single">Each day of use</td>
<td class="left"></td>
</tr>
<tr>
<td class="left border-right-single">Hemoglobinometer</td>
<td class="left border-right-single">Standardize against cyanmethemoglobin standard</td>
<td class="left border-right-single">......do</td>
<td class="left"></td>
</tr>
<tr>
<td class="left border-right-single">Refractometer</td>
<td class="left border-right-single">Standardize against distilled water</td>
<td class="left border-right-single">......do</td>
<td class="left"></td>
</tr>
<tr>
<td class="left border-right-single">Blood container scale</td>
<td class="left border-right-single">Standardize against container of known weight</td>
<td class="left border-right-single">......do</td>
<td class="left">As necessary.</td>
</tr>
<tr>
<td class="left border-right-single">Water bath</td>
<td class="left border-right-single">Observe temperature</td>
<td class="left border-right-single">......do</td>
<td class="left"> Do.</td>
</tr>
<tr>
<td class="left border-right-single">Rh view box</td>
<td class="left border-right-single">......do</td>
<td class="left border-right-single">......do</td>
<td class="left"> Do.</td>
</tr>
<tr>
<td class="left border-right-single">Autoclave</td>
<td class="left border-right-single">......do</td>
<td class="left border-right-single">Each time of use</td>
<td class="left"> Do.</td>
</tr>
<tr>
<td class="left border-right-single">Serologic rotators</td>
<td class="left border-right-single">Observe controls for correct results</td>
<td class="left border-right-single">Each day of use</td>
<td class="left">Speed as necessary.</td>
</tr>
<tr>
<td class="left border-right-single">Laboratory thermometers</td>
<td class="left border-right-single"></td>
<td class="left border-right-single"></td>
<td class="left">Before initial use.</td>
</tr>
<tr>
<td class="left border-right-single">Electronic thermometers</td>
<td class="left border-right-single"></td>
<td class="left border-right-single"></td>
<td class="left">Monthly.</td>
</tr>
<tr>
<td class="left border-bottom-single border-right-single">Vacuum blood agitator</td>
<td class="left border-bottom-single border-right-single">Observe weight of the first container of blood filled for correct results</td>
<td class="left border-bottom-single border-right-single">Each day of use</td>
<td class="left border-bottom-single">Standardize with container of known mass or volume before initial use, and after repairs or adjustments.</td>
</tr>
</tbody>
</table></div>
</div>
</div>
<div id="p-606.60(c)"><p class="indent-1" data-title="606.60(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> Equipment employed in the sterilization of materials used in blood collection or for disposition of contaminated products shall be designed, maintained and utilized to ensure the destruction of contaminating microorganisms. The effectiveness of the sterilization procedure shall be no less than that achieved by an attained temperature of 121.5 °C (251 °F) maintained for 20 minutes by saturated steam or by an attained temperature of 170 °C (338 °F) maintained for 2 hours with dry heat.</p></div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/40-FR-53532" class="fr-reference" data-reference="40 FR 53532">40 FR 53532</a>, Nov. 18, 1975; <a href="https://www.federalregister.gov/citation/40-FR-55849" class="fr-reference" data-reference="40 FR 55849">40 FR 55849</a>, Dec. 2, 1975, as amended at <a href="https://www.federalregister.gov/citation/45-FR-9261" class="fr-reference" data-reference="45 FR 9261">45 FR 9261</a>, Feb. 12, 1980; <a href="https://www.federalregister.gov/citation/57-FR-11263" class="fr-reference" data-reference="57 FR 11263">57 FR 11263</a>, Apr. 2, 1992; <a href="https://www.federalregister.gov/citation/57-FR-12862" class="fr-reference" data-reference="57 FR 12862">57 FR 12862</a>, Apr. 13, 1992]
</p>
</div>

<div class="section" id="606.65">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.65","citation":"21 CFR 606.65"}'>§ 606.65 Supplies and reagents.</h4>
<p>All supplies and reagents used in the collection, processing, compatibility testing, storage and distribution of blood and blood components shall be stored in a safe, sanitary and orderly manner.</p>
<div id="p-606.65(a)">
<p class="indent-1" data-title="606.65(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> All surfaces coming in contact with blood and blood components intended for transfusion shall be sterile, pyrogen-free, and shall not interact with the product in such a manner as to have an adverse effect upon the safety, purity, potency or effectiveness of the product. All final containers and closures for blood and blood components not intended for transfusion shall be clean and free of surface solids and other contaminants.</p>
</div>
<div id="p-606.65(b)">
<p class="indent-1" data-title="606.65(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> Each blood collecting container and its satellite container(s), if any, shall be examined visually for damage or evidence of contamination prior to its use and immediately after filling. Such examination shall include inspection for breakage of seals, when indicated, and abnormal discoloration. Where any defect is observed, the container shall not be used, or, if detected after filling, shall be properly discarded.</p>
</div>
<div id="p-606.65(c)">
<p class="indent-1" data-title="606.65(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> Representative samples of each lot of the following reagents or solutions shall be tested on a regularly scheduled basis by methods described in the Standard Operating Procedures Manual to determine their capacity to perform as required:</p>
<div class="table-wrapper">
<div class="gpotbl_div"><table border="1" cellpadding="1" cellspacing="1" class="gpo_table" frame="void" width="100%">
<thead>
<tr>
<th class="center border-top-single border-bottom-single border-right-single">Reagent or solution</th>
<th class="center border-top-single border-bottom-single">Frequency of testing</th>
</tr>
</thead>
<tbody>
<tr>
<td class="left border-right-single">Anti-human globulin</td>
<td class="left">Each day of use.</td>
</tr>
<tr>
<td class="left border-right-single">Blood grouping reagents</td>
<td class="left"> Do.</td>
</tr>
<tr>
<td class="left border-right-single">Lectins</td>
<td class="left"> Do.</td>
</tr>
<tr>
<td class="left border-right-single">Antibody screening and reverse grouping cells</td>
<td class="left"> Do.</td>
</tr>
<tr>
<td class="left border-right-single">Hepatitis test reagents</td>
<td class="left">Each run.</td>
</tr>
<tr>
<td class="left border-right-single">Syphilis serology reagents</td>
<td class="left"> Do.</td>
</tr>
<tr>
<td class="left border-bottom-single border-right-single">Enzymes</td>
<td class="left border-bottom-single">Each day of use.</td>
</tr>
</tbody>
</table></div>
</div>
</div>
<div id="p-606.65(d)">
<p class="indent-1" data-title="606.65(d)"><span class="paragraph-hierarchy"><span class="paren">(</span>d<span class="paren">)</span></span> Supplies and reagents that do not bear an expiration date shall be stored in such a manner that the oldest is used first.</p>
</div>
<div id="p-606.65(e)">
<p class="indent-1" data-title="606.65(e)"><span class="paragraph-hierarchy"><span class="paren">(</span>e<span class="paren">)</span></span> Supplies and reagents shall be used in a manner consistent with instructions provided by the manufacturer.</p>
</div>
<div id="p-606.65(f)"><p class="indent-1" data-title="606.65(f)"><span class="paragraph-hierarchy"><span class="paren">(</span>f<span class="paren">)</span></span> Items that are required to be sterile and come into contact with blood should be disposable whenever possible.</p></div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/40-FR-53532" class="fr-reference" data-reference="40 FR 53532">40 FR 53532</a>, Nov. 18, 1975, as amended at <a href="https://www.federalregister.gov/citation/59-FR-23636" class="fr-reference" data-reference="59 FR 23636">59 FR 23636</a>, May 6, 1994]
</p>
</div>

</div>

<div class="subpart" id="subpart-E"><h2 data-hierarchy-metadata="{&quot;path&quot;:&quot;/current/title-21/part-606/subpart-E&quot;,&quot;citation&quot;:&quot;21 CFR Part 606 Subpart E&quot;}">Subpart E [Reserved]</h2>
</div>

<div class="subpart" id="subpart-F"><h2 data-hierarchy-metadata="{&quot;path&quot;:&quot;/current/title-21/part-606/subpart-F&quot;,&quot;citation&quot;:&quot;21 CFR Part 606 Subpart F&quot;}">Subpart F—Production and Process Controls</h2>
<div class="section" id="606.100">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.100","citation":"21 CFR 606.100"}'>§ 606.100 Standard operating procedures.</h4>
<div id="p-606.100(a)">
<p class="indent-1" data-title="606.100(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> In all instances, except clinical investigations, standard operating procedures shall comply with published additional standards in <a href="/current/title-21/part-640" class="cfr external">part 640 of this chapter</a> for the products being processed; except that, references in part 640 relating to licenses, licensed establishments and submission of material or data to or approval by the Director, Center for Biologics Evaluation and Research, are not applicable to establishments not subject to licensure under section 351 of the Public Health Service Act.</p>
</div>
<div id="p-606.100(b)">
<p class="indent-1" data-title="606.100(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> Establishments must establish, maintain, and follow written standard operating procedures for all steps in the collection, processing, compatibility testing, storage, and distribution of blood and blood components for allogeneic transfusion, autologous transfusion, and further manufacturing purposes; for all steps in the investigation of product deviations related to <a href="/current/title-21/section-606.171" class="cfr external">§ 606.171</a>; and for all steps in recordkeeping related to current good manufacturing practice and other applicable requirements and standards. Such procedures must be available to the personnel for use in the areas where the procedures are performed. The written standard operating procedures must include, but are not limited to, descriptions of the following, when applicable:</p>
<div id="p-606.100(b)(1)">
<p class="indent-2" data-title="606.100(b)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> Criteria used to determine donor eligibility, including acceptable medical history criteria.</p>
</div>
<div id="p-606.100(b)(2)">
<p class="indent-2" data-title="606.100(b)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> Methods of performing donor qualifying tests and measurements, including minimum and maximum values for a test or procedure when a factor in determining acceptability.</p>
</div>
<div id="p-606.100(b)(3)">
<p class="indent-2" data-title="606.100(b)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> Solutions and methods used to prepare the site of phlebotomy to give maximum assurance of a sterile container of blood.</p>
</div>
<div id="p-606.100(b)(4)">
<p class="indent-2" data-title="606.100(b)(4)"><span class="paragraph-hierarchy"><span class="paren">(</span>4<span class="paren">)</span></span> Method of accurately relating the product(s) to the donor.</p>
</div>
<div id="p-606.100(b)(5)">
<p class="indent-2" data-title="606.100(b)(5)"><span class="paragraph-hierarchy"><span class="paren">(</span>5<span class="paren">)</span></span> Blood collection procedure, including in-process precautions taken to measure accurately the quantity of blood removed from the donor.</p>
</div>
<div id="p-606.100(b)(6)">
<p class="indent-2" data-title="606.100(b)(6)"><span class="paragraph-hierarchy"><span class="paren">(</span>6<span class="paren">)</span></span> Methods of component preparation, including any time restrictions for specific steps in processing.</p>
</div>
<div id="p-606.100(b)(7)">
<p class="indent-2" data-title="606.100(b)(7)"><span class="paragraph-hierarchy"><span class="paren">(</span>7<span class="paren">)</span></span> All tests and repeat tests performed on blood and blood components during manufacturing.</p>
</div>
<div id="p-606.100(b)(8)">
<p class="indent-2" data-title="606.100(b)(8)"><span class="paragraph-hierarchy"><span class="paren">(</span>8<span class="paren">)</span></span> Pretransfusion testing, where applicable, including precautions to be taken to identify accurately the recipient blood samples and crossmatched donor units.</p>
</div>
<div id="p-606.100(b)(9)">
<p class="indent-2" data-title="606.100(b)(9)"><span class="paragraph-hierarchy"><span class="paren">(</span>9<span class="paren">)</span></span> Procedures for investigating adverse donor and recipient reactions.</p>
</div>
<div id="p-606.100(b)(10)">
<p class="indent-2" data-title="606.100(b)(10)"><span class="paragraph-hierarchy"><span class="paren">(</span>10<span class="paren">)</span></span> Storage temperatures and methods of controlling storage temperatures for all blood products and reagents as prescribed in <a href="/current/title-21/section-600.15" class="cfr external">§§ 600.15</a> and <a href="/current/title-21/section-610.53" class="cfr external">610.53 of this chapter</a>.</p>
</div>
<div id="p-606.100(b)(11)">
<p class="indent-2" data-title="606.100(b)(11)"><span class="paragraph-hierarchy"><span class="paren">(</span>11<span class="paren">)</span></span> Length of expiration dates, if any, assigned for all final products as prescribed in <a href="/current/title-21/section-610.53" class="cfr external">§ 610.53 of this chapter</a>.</p>
</div>
<div id="p-606.100(b)(12)">
<p class="indent-2" data-title="606.100(b)(12)"><span class="paragraph-hierarchy"><span class="paren">(</span>12<span class="paren">)</span></span> Criteria for determining whether returned blood is suitable for reissue.</p>
</div>
<div id="p-606.100(b)(13)">
<p class="indent-2" data-title="606.100(b)(13)"><span class="paragraph-hierarchy"><span class="paren">(</span>13<span class="paren">)</span></span> Procedures used for relating a unit of blood or blood component from the donor to its final disposition.</p>
</div>
<div id="p-606.100(b)(14)">
<p class="indent-2" data-title="606.100(b)(14)"><span class="paragraph-hierarchy"><span class="paren">(</span>14<span class="paren">)</span></span> Quality control procedures for supplies and reagents employed in blood collection, processing and pretransfusion testing.</p>
</div>
<div id="p-606.100(b)(15)">
<p class="indent-2" data-title="606.100(b)(15)"><span class="paragraph-hierarchy"><span class="paren">(</span>15<span class="paren">)</span></span> Schedules and procedures for equipment maintenance and calibration.</p>
</div>
<div id="p-606.100(b)(16)">
<p class="indent-2" data-title="606.100(b)(16)"><span class="paragraph-hierarchy"><span class="paren">(</span>16<span class="paren">)</span></span> Labeling procedures, including safeguards to avoid labeling mixups.</p>
</div>
<div id="p-606.100(b)(17)">
<p class="indent-2" data-title="606.100(b)(17)"><span class="paragraph-hierarchy"><span class="paren">(</span>17<span class="paren">)</span></span> Procedures of plasmapheresis, plateletpheresis, and leukapheresis, if performed, including precautions to be taken to ensure reinfusion of a donor's own cells.</p>
</div>
<div id="p-606.100(b)(18)">
<p class="indent-2" data-title="606.100(b)(18)"><span class="paragraph-hierarchy"><span class="paren">(</span>18<span class="paren">)</span></span> Procedures for preparing recovered plasma, if performed, including details of separation, pooling, labeling, storage, and distribution.</p>
</div>
<div id="p-606.100(b)(19)">
<p class="indent-2" data-title="606.100(b)(19)"><span class="paragraph-hierarchy"><span class="paren">(</span>19<span class="paren">)</span></span> Procedures under <a href="/current/title-21/section-610.46" class="cfr external">§§ 610.46</a> and <a href="/current/title-21/section-610.47" class="cfr external">610.47 of this chapter</a>:</p>
<div id="p-606.100(b)(19)(i)">
<p class="indent-3" data-title="606.100(b)(19)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> To identify previously donated blood and blood components from a donor who later tests reactive for evidence of human immunodeficiency virus (HIV) infection or hepatitis C virus (HCV) infection when tested under <a href="/current/title-21/section-610.40" class="cfr external">§ 610.40 of this chapter</a>, or when a blood establishment is made aware of other reliable test results or information indicating evidence of HIV or HCV infection;</p>
</div>
<div id="p-606.100(b)(19)(ii)">
<p class="indent-3" data-title="606.100(b)(19)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> To quarantine in-date blood and blood components previously donated by such a donor that are intended for use in another person or further manufacture into injectable products, except pooled components intended solely for further manufacturing into products that are manufactured using validated viral clearance procedures;</p>
</div>
<div id="p-606.100(b)(19)(iii)">
<p class="indent-3" data-title="606.100(b)(19)(iii)"><span class="paragraph-hierarchy"><span class="paren">(</span>iii<span class="paren">)</span></span> To notify consignees to quarantine in-date blood and blood components previously donated by such a donor intended for use in another person or for further manufacture into injectable products, except pooled components intended solely for further manufacturing into products that are manufactured using validated viral clearance procedures;</p>
</div>
<div id="p-606.100(b)(19)(iv)">
<p class="indent-3" data-title="606.100(b)(19)(iv)"><span class="paragraph-hierarchy"><span class="paren">(</span>iv<span class="paren">)</span></span> To determine the suitability for release, destruction, or relabeling of quarantined in-date blood and blood components;</p>
</div>
<div id="p-606.100(b)(19)(v)">
<p class="indent-3" data-title="606.100(b)(19)(v)"><span class="paragraph-hierarchy"><span class="paren">(</span>v<span class="paren">)</span></span> To notify consignees of the results of the HIV or HCV testing performed on the donors of such blood and blood components;</p>
</div>
<div id="p-606.100(b)(19)(vi)">
<p class="indent-3" data-title="606.100(b)(19)(vi)"><span class="paragraph-hierarchy"><span class="paren">(</span>vi<span class="paren">)</span></span> To notify the transfusion recipient, the recipient's physician of record, or the recipient's legal representative that the recipient received blood or blood components at increased risk of transmitting HIV or HCV, respectively.</p>
</div>
</div>
<div id="p-606.100(b)(20)">
<p class="indent-2" data-title="606.100(b)(20)"><span class="paragraph-hierarchy"><span class="paren">(</span>20<span class="paren">)</span></span> Procedures for donor deferral as prescribed in <a href="/current/title-21/section-610.41" class="cfr external">§ 610.41 of this chapter</a>.</p>
</div>
<div id="p-606.100(b)(21)">
<p class="indent-2" data-title="606.100(b)(21)"><span class="paragraph-hierarchy"><span class="paren">(</span>21<span class="paren">)</span></span> Procedures for donor notification and notification of the referring physician of an autologous donor, including procedures for the appropriate followup if the initial attempt at notification fails, as prescribed in <a href="/current/title-21/section-630.40" class="cfr external">§ 630.40 of this chapter</a>.</p>
</div>
<div id="p-606.100(b)(22)">
<p class="indent-2" data-title="606.100(b)(22)"><span class="paragraph-hierarchy"><span class="paren">(</span>22<span class="paren">)</span></span> Procedures to control the risks of bacterial contamination of platelets, including all steps required under <a href="/current/title-21/section-606.145" class="cfr external">§ 606.145</a>.</p>
</div>
</div>
<div id="p-606.100(c)">
<p class="indent-1" data-title="606.100(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> All records pertinent to the lot or unit maintained pursuant to these regulations shall be reviewed before the release or distribution of a lot or unit of final product. The review or portions of the review may be performed at appropriate periods during or after blood collecting, processing, compatibility testing and storing. A thorough investigation, including the conclusions and followup, of any unexplained discrepancy or the failure of a lot or unit to meet any of its specifications shall be made and recorded.</p>
</div>
<div id="p-606.100(d)">
<p class="indent-1" data-title="606.100(d)"><span class="paragraph-hierarchy"><span class="paren">(</span>d<span class="paren">)</span></span> In addition to the requirements of this subpart and in conformity with this section, any facility may utilize current standard operating procedures such as the manuals of the organizations, as long as such specific procedures are consistent with, and at least as stringent as, the requirements contained in this part.</p>
<div id="p-606.100(d)(1)">
<p class="indent-2" data-title="606.100(d)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> American Association of Blood Banks.</p>
</div>
<div id="p-606.100(d)(2)">
<p class="indent-2" data-title="606.100(d)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> American National Red Cross.</p>
</div>
<div id="p-606.100(d)(3)"><p class="indent-2" data-title="606.100(d)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> Other organizations or individual blood banks, subject to approval by the Director, Center for Biologics Evaluation and Research.</p></div>
</div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/40-FR-53532" class="fr-reference" data-reference="40 FR 53532">40 FR 53532</a>, Nov. 18, 1975, as amended at <a href="https://www.federalregister.gov/citation/49-FR-23833" class="fr-reference" data-reference="49 FR 23833">49 FR 23833</a>, June 8, 1984; <a href="https://www.federalregister.gov/citation/55-FR-11013" class="fr-reference" data-reference="55 FR 11013">55 FR 11013</a>, Mar. 26, 1990; <a href="https://www.federalregister.gov/citation/61-FR-47422" class="fr-reference" data-reference="61 FR 47422">61 FR 47422</a>, Sept. 9, 1996; <a href="https://www.federalregister.gov/citation/64-FR-45370" class="fr-reference" data-reference="64 FR 45370">64 FR 45370</a>, Aug. 19, 1999; <a href="https://www.federalregister.gov/citation/66-FR-31176" class="fr-reference" data-reference="66 FR 31176">66 FR 31176</a>, June 11, 2001; <a href="https://www.federalregister.gov/citation/72-FR-48798" class="fr-reference" data-reference="72 FR 48798">72 FR 48798</a>, Aug. 24, 2007; <a href="https://www.federalregister.gov/citation/80-FR-80651" class="fr-reference" data-reference="80 FR 80651">80 FR 80651</a>, Dec. 28, 2015; <a href="https://www.federalregister.gov/citation/80-FR-29895" class="fr-reference" data-reference="80 FR 29895">80 FR 29895</a>, May 22, 2015]
</p>
</div>

<div class="section" id="606.110">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.110","citation":"21 CFR 606.110"}'>§ 606.110 Plateletpheresis, leukapheresis, and plasmapheresis.</h4>
<div id="p-606.110(a)">
<p class="indent-1" data-title="606.110(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> The use of plateletpheresis and leukapheresis procedures to obtain a product for a specific recipient may be at variance with the additional standards for specific products prescribed in this part provided that: </p>
<div id="p-606.110(a)(1)"><p class="indent-2" data-title="606.110(a)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> A physician has determined that the recipient must be transfused with the leukocytes or platelets from a specific donor, and </p></div>
<div id="p-606.110(a)(2)">
<p class="indent-2" data-title="606.110(a)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> the procedure is performed under the supervision of a responsible physician who is aware of the health status of the donor, and the physician has determined and documented that the donor's health permits plateletpheresis or leukapheresis.</p>
</div>
</div>
<div id="p-606.110(b)"><p class="indent-1" data-title="606.110(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> Plasmapheresis of donors who do not meet the donor requirements of <a href="/current/title-21/section-630.10" class="cfr external">§§ 630.10</a>, <a href="/current/title-21/section-630.15" class="cfr external">630.15</a>, <a href="/current/title-21/section-640.64" class="cfr external">640.64</a> and <a href="/current/title-21/section-640.65" class="cfr external">640.65 of this chapter</a> for the collection of plasma containing rare antibodies shall be permitted only with the prior approval of the Director, Center for Biologics Evaluation and Research.</p></div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/40-FR-53532" class="fr-reference" data-reference="40 FR 53532">40 FR 53532</a>, Nov. 18, 1975, as amended at <a href="https://www.federalregister.gov/citation/49-FR-23833" class="fr-reference" data-reference="49 FR 23833">49 FR 23833</a>, June 8, 1984; <a href="https://www.federalregister.gov/citation/55-FR-11013" class="fr-reference" data-reference="55 FR 11013">55 FR 11013</a>, Mar. 26, 1990; <a href="https://www.federalregister.gov/citation/80-FR-29895" class="fr-reference" data-reference="80 FR 29895">80 FR 29895</a>, May 22, 2015]
</p>
</div>

</div>

<div class="subpart" id="subpart-G"><h2 data-hierarchy-metadata="{&quot;path&quot;:&quot;/current/title-21/part-606/subpart-G&quot;,&quot;citation&quot;:&quot;21 CFR Part 606 Subpart G&quot;}">Subpart G—Additional Labeling Standards for Blood and Blood Components</h2>
<div class="section" id="606.120">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.120","citation":"21 CFR 606.120"}'>§ 606.120 Labeling, general requirements.</h4>
<div id="p-606.120(a)">
<p class="indent-1" data-title="606.120(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> Labeling operations shall be separated physically or spatially from other operations in a manner adequate to prevent mixups.</p>
</div>
<div id="p-606.120(b)">
<p class="indent-1" data-title="606.120(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> The labeling operation shall include the following labeling controls:</p>
<div id="p-606.120(b)(1)">
<p class="indent-2" data-title="606.120(b)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> Labels shall be held upon receipt, pending review and proofing against an approved final copy, to ensure accuracy regarding identity, content, and conformity with the approved copy.</p>
</div>
<div id="p-606.120(b)(2)">
<p class="indent-2" data-title="606.120(b)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> Each type of label representing different products shall be stored and maintained in a manner to prevent mixups, and stocks of obsolete labels shall be destroyed.</p>
</div>
<div id="p-606.120(b)(3)">
<p class="indent-2" data-title="606.120(b)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> All necessary checks in labeling procedures shall be utilized to prevent errors in translating test results to container labels.</p>
</div>
</div>
<div id="p-606.120(c)"><p class="indent-1" data-title="606.120(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> All labeling shall be clear and legible.</p></div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/50-FR-35469" class="fr-reference" data-reference="50 FR 35469">50 FR 35469</a>, Aug. 30, 1985]
</p>
</div>

<div class="section" id="606.121">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.121","citation":"21 CFR 606.121"}'>§ 606.121 Container label.</h4>
<div id="p-606.121(a)">
<p class="indent-1" data-title="606.121(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> The container label requirements are designed to facilitate the use of a uniform container label for blood and blood components intended for use in transfusion or further manufacture by all blood establishments.</p>
</div>
<div id="p-606.121(b)">
<p class="indent-1" data-title="606.121(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> The label provided by the collecting facility and the initial processing facility must not be removed, altered, or obscured, except that the label may be altered to indicate the proper name of the product, with any appropriate modifiers and attributes, and other information required to identify accurately the contents of a container after blood components considered finished products have been prepared.</p>
</div>
<div id="p-606.121(c)">
<p class="indent-1" data-title="606.121(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> The container label must include the following information, as well as other specialized information as required in this section for specific products:</p>
<div id="p-606.121(c)(1)">
<p class="indent-2" data-title="606.121(c)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> The proper name of the product in a prominent position, with any appropriate modifiers and attributes.</p>
</div>
<div id="p-606.121(c)(2)">
<p class="indent-2" data-title="606.121(c)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> The name, address, unique facility identifier, and, if a licensed product, the license number of each manufacturer; except the container label for blood and blood components for further manufacture is not required to include a unique facility identifier.</p>
</div>
<div id="p-606.121(c)(3)">
<p class="indent-2" data-title="606.121(c)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> The donor or lot number relating the unit to the donor. If pooled, all donor numbers, all donation numbers, or a pool number that is traceable to each individual unit comprising the pool.</p>
</div>
<div id="p-606.121(c)(4)">
<p class="indent-2" data-title="606.121(c)(4)"><span class="paragraph-hierarchy"><span class="paren">(</span>4<span class="paren">)</span></span> </p>
<div id="p-606.121(c)(4)(i)">
<p class="indent-3" data-title="606.121(c)(4)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> The expiration date, including the day, month, and year, and, if the dating period for the product is 72 hours or less, including any product prepared in a system that might compromise sterility, the hour of expiration.</p>
</div>
<div id="p-606.121(c)(4)(ii)">
<p class="indent-3" data-title="606.121(c)(4)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> If Source Plasma intended for manufacturing into noninjectable products is pooled, the expiration date for the pool is determined from the collection date of the oldest unit in the pool, and the pooling records must show the collection date for each unit in the pool.</p>
</div>
</div>
<div id="p-606.121(c)(5)">
<p class="indent-2" data-title="606.121(c)(5)"><span class="paragraph-hierarchy"><span class="paren">(</span>5<span class="paren">)</span></span> For Whole Blood, Plasma, Platelets, and partial units of Red Blood Cells, the volume of the product, accurate to within ±10 percent; or optionally for Platelets, the volume or volume range within reasonable limits.</p>
</div>
<div id="p-606.121(c)(6)">
<p class="indent-2" data-title="606.121(c)(6)"><span class="paragraph-hierarchy"><span class="paren">(</span>6<span class="paren">)</span></span> Where applicable, the name and volume of source material.</p>
</div>
<div id="p-606.121(c)(7)">
<p class="indent-2" data-title="606.121(c)(7)"><span class="paragraph-hierarchy"><span class="paren">(</span>7<span class="paren">)</span></span> The recommended storage temperature (in degrees Celsius).</p>
</div>
<div id="p-606.121(c)(8)">
<p class="indent-2" data-title="606.121(c)(8)"><span class="paragraph-hierarchy"><span class="paren">(</span>8<span class="paren">)</span></span> If the product is intended for transfusion, the statements:</p>
<div id="p-606.121(c)(8)(i)">
<p class="indent-3" data-title="606.121(c)(8)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> “Rx only.”</p>
</div>
<div id="p-606.121(c)(8)(ii)">
<p class="indent-3" data-title="606.121(c)(8)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> “See circular of information for indications, contraindications, cautions, and methods of infusion.”</p>
</div>
<div id="p-606.121(c)(8)(iii)">
<p class="indent-3" data-title="606.121(c)(8)(iii)"><span class="paragraph-hierarchy"><span class="paren">(</span>iii<span class="paren">)</span></span> “Properly identify intended recipient.”</p>
</div>
<div id="p-606.121(c)(8)(iv)">
<p class="indent-3" data-title="606.121(c)(8)(iv)"><span class="paragraph-hierarchy"><span class="paren">(</span>iv<span class="paren">)</span></span> “This product may transmit infectious agents.”</p>
</div>
<div id="p-606.121(c)(8)(v)">
<p class="indent-3" data-title="606.121(c)(8)(v)"><span class="paragraph-hierarchy"><span class="paren">(</span>v<span class="paren">)</span></span> The appropriate donor classification statement, <em>i.e.,</em> “paid donor” or “volunteer donor,” in no less prominence than the proper name of the product.</p>
<div id="p-606.121(c)(8)(v)(A)">
<p class="indent-4" data-title="606.121(c)(8)(v)(A)"><span class="paragraph-hierarchy"><span class="paren">(</span>A<span class="paren">)</span></span> A paid donor is a person who receives monetary payment for a blood donation.</p>
</div>
<div id="p-606.121(c)(8)(v)(B)">
<p class="indent-4" data-title="606.121(c)(8)(v)(B)"><span class="paragraph-hierarchy"><span class="paren">(</span>B<span class="paren">)</span></span> A volunteer donor is a person who does not receive monetary payment for a blood donation.</p>
</div>
<div id="p-606.121(c)(8)(v)(C)">
<p class="indent-4" data-title="606.121(c)(8)(v)(C)"><span class="paragraph-hierarchy"><span class="paren">(</span>C<span class="paren">)</span></span> Benefits, such as time off from work, membership in blood assurance programs, and cancellation of nonreplacement fees that are not readily convertible to cash, do not constitute monetary payment within the meaning of this paragraph.</p>
</div>
</div>
</div>
<div id="p-606.121(c)(9)">
<p class="indent-2" data-title="606.121(c)(9)"><span class="paragraph-hierarchy"><span class="paren">(</span>9<span class="paren">)</span></span> If the product is intended for transfusion or as is otherwise appropriate, the ABO group and Rh type of the donor must be designated conspicuously. For Cryoprecipitated Antihemophiliac Factor (AHF), the Rh type may be omitted. The Rh type must be designated as follows:</p>
<div id="p-606.121(c)(9)(i)">
<p class="indent-3" data-title="606.121(c)(9)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> If the test using Anti-D Blood Grouping Reagent is positive, the product must be labeled: “Rh positive.”</p>
</div>
<div id="p-606.121(c)(9)(ii)">
<p class="indent-3" data-title="606.121(c)(9)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> If the test using Anti-D Blood Grouping Reagent is negative, but the test for weak D (formerly D<sub>u</sub>) is positive, the product must be labeled: “Rh positive.”</p>
</div>
<div id="p-606.121(c)(9)(iii)">
<p class="indent-3" data-title="606.121(c)(9)(iii)"><span class="paragraph-hierarchy"><span class="paren">(</span>iii<span class="paren">)</span></span> If the test using Anti-D Blood Grouping Reagent is negative and the test for weak D (formerly D<sub>u</sub>) is negative, the product must be labeled: “Rh negative.”</p>
</div>
</div>
<div id="p-606.121(c)(10)">
<p class="indent-2" data-title="606.121(c)(10)"><span class="paragraph-hierarchy"><span class="paren">(</span>10<span class="paren">)</span></span> If the product is not intended for transfusion, a statement as applicable: “Caution: For Manufacturing Use Only,” or “Caution: For Use in Manufacturing Noninjectable Products Only,” or other cautionary statement as approved by the Director, Center for Biologics Evaluation and Research (CBER).</p>
</div>
<div id="p-606.121(c)(11)">
<p class="indent-2" data-title="606.121(c)(11)"><span class="paragraph-hierarchy"><span class="paren">(</span>11<span class="paren">)</span></span> If the product is intended for further manufacturing use, a statement listing the results of all the tests for relevant transfusion-transmitted infections required under <a href="/current/title-21/section-610.40" class="cfr external">§ 610.40 of this chapter</a> for which the donation has been tested and found negative; except that the container label for Source Plasma is not required to list the negative results of serological syphilis testing under <a href="/current/title-21/section-640.65#p-640.65(b)" class="cfr external">§ 640.65(b) of this chapter</a>.</p>
</div>
<div id="p-606.121(c)(12)">
<p class="indent-2" data-title="606.121(c)(12)"><span class="paragraph-hierarchy"><span class="paren">(</span>12<span class="paren">)</span></span> The blood and blood components must be labeled in accordance with <a href="/current/title-21/section-610.40" class="cfr external">§ 610.40 of this chapter</a>, when the donation is tested and demonstrates evidence of infection due to a relevant transfusion-transmitted infection(s).</p>
</div>
<div id="p-606.121(c)(13)">
<p class="indent-2" data-title="606.121(c)(13)"><span class="paragraph-hierarchy"><span class="paren">(</span>13<span class="paren">)</span></span> The container label of blood or blood components intended for transfusion must bear encoded information in a format that is machine-readable and approved for use by the Director, CBER.</p>
<div id="p-606.121(c)(13)(i)">
<p class="indent-3" data-title="606.121(c)(13)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> <em class="paragraph-heading">Who is subject to this machine-readable requirement?</em>  All blood establishments that manufacture, process, repack, or relabel blood or blood components intended for transfusion and regulated under the Federal Food, Drug, and Cosmetic Act or the Public Health Service Act.</p>
</div>
<div id="p-606.121(c)(13)(ii)">
<p class="indent-3" data-title="606.121(c)(13)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> <em class="paragraph-heading">What blood products are subject to this machine-readable requirement?</em>  All blood and blood components intended for transfusion are subject to the machine-readable information label requirement in this section.</p>
</div>
<div id="p-606.121(c)(13)(iii)">
<p class="indent-3" data-title="606.121(c)(13)(iii)"><span class="paragraph-hierarchy"><span class="paren">(</span>iii<span class="paren">)</span></span> <em class="paragraph-heading">What information must be machine-readable?</em>  Each label must have machine-readable information that contains, at a minimum:</p>
<div id="p-606.121(c)(13)(iii)(A)">
<p class="indent-4" data-title="606.121(c)(13)(iii)(A)"><span class="paragraph-hierarchy"><span class="paren">(</span>A<span class="paren">)</span></span> A unique facility identifier;</p>
</div>
<div id="p-606.121(c)(13)(iii)(B)">
<p class="indent-4" data-title="606.121(c)(13)(iii)(B)"><span class="paragraph-hierarchy"><span class="paren">(</span>B<span class="paren">)</span></span> Lot number relating to the donor;</p>
</div>
<div id="p-606.121(c)(13)(iii)(C)">
<p class="indent-4" data-title="606.121(c)(13)(iii)(C)"><span class="paragraph-hierarchy"><span class="paren">(</span>C<span class="paren">)</span></span> Product code; and</p>
</div>
<div id="p-606.121(c)(13)(iii)(D)">
<p class="indent-4" data-title="606.121(c)(13)(iii)(D)"><span class="paragraph-hierarchy"><span class="paren">(</span>D<span class="paren">)</span></span> ABO and Rh of the donor, except as described in <a href="/current/title-21/section-606.121#p-606.121(c)(9)" class="cfr external">paragraphs (c)(9)</a> and <a href="/current/title-21/section-606.121#p-606.121(i)(5)" class="cfr external">(i)(5)</a> of this section.</p>
</div>
</div>
<div id="p-606.121(c)(13)(iv)">
<p class="indent-3" data-title="606.121(c)(13)(iv)"><span class="paragraph-hierarchy"><span class="paren">(</span>iv<span class="paren">)</span></span> <em class="paragraph-heading">How must the machine-readable information appear?</em>  The machine-readable information must:</p>
<div id="p-606.121(c)(13)(iv)(A)">
<p class="indent-4" data-title="606.121(c)(13)(iv)(A)"><span class="paragraph-hierarchy"><span class="paren">(</span>A<span class="paren">)</span></span> Be unique to the blood or blood component;</p>
</div>
<div id="p-606.121(c)(13)(iv)(B)">
<p class="indent-4" data-title="606.121(c)(13)(iv)(B)"><span class="paragraph-hierarchy"><span class="paren">(</span>B<span class="paren">)</span></span> Be surrounded by sufficient blank space so that the machine-readable information can be scanned correctly; and</p>
</div>
<div id="p-606.121(c)(13)(iv)(C)">
<p class="indent-4" data-title="606.121(c)(13)(iv)(C)"><span class="paragraph-hierarchy"><span class="paren">(</span>C<span class="paren">)</span></span> Remain intact under normal conditions of use.</p>
</div>
</div>
<div id="p-606.121(c)(13)(v)">
<p class="indent-3" data-title="606.121(c)(13)(v)"><span class="paragraph-hierarchy"><span class="paren">(</span>v<span class="paren">)</span></span> <em class="paragraph-heading">Where does the machine-readable information go?</em>  The machine-readable information must appear on the label of any blood or blood component which is or can be transfused to a patient or from which the blood or blood component can be taken and transfused to a patient.</p>
</div>
</div>
</div>
<div id="p-606.121(d)">
<p class="indent-1" data-title="606.121(d)"><span class="paragraph-hierarchy"><span class="paren">(</span>d<span class="paren">)</span></span> Unless otherwise approved by the Director, CBER, the container label for blood and blood components intended for transfusion must be white and print must be solid black, with the following additional exceptions:</p>
<div id="p-606.121(d)(1)">
<p class="indent-2" data-title="606.121(d)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> The ABO and Rh blood groups must be printed as follows:</p>
<div id="p-606.121(d)(1)(i)">
<p class="indent-3" data-title="606.121(d)(1)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> Rh positive: Use black print on white background and use solid black or other solid color for ABO.</p>
</div>
<div id="p-606.121(d)(1)(ii)">
<p class="indent-3" data-title="606.121(d)(1)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> Rh negative: Use white print on black background for Rh and use black outline on a white background for ABO.</p>
</div>
</div>
<div id="p-606.121(d)(2)">
<p class="indent-2" data-title="606.121(d)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> The proper name of the product, with any appropriate modifiers and attributes, the donor classification statement, and the statement “properly identify intended recipient” may be printed in solid red or in solid black.</p>
</div>
<div id="p-606.121(d)(3)">
<p class="indent-2" data-title="606.121(d)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> The following color scheme may be used for differentiating ABO Blood groups:</p>
<div class="table-wrapper">
<div class="gpotbl_div"><table border="1" cellpadding="1" cellspacing="1" class="gpo_table" frame="void" width="100%">
<thead>
<tr>
<th class="center border-top-single border-bottom-single border-right-single">Blood group</th>
<th class="center border-top-single border-bottom-single">Color of label</th>
</tr>
</thead>
<tbody>
<tr>
<td class="left border-right-single">O</td>
<td class="left">Blue</td>
</tr>
<tr>
<td class="left border-right-single">A</td>
<td class="left">Yellow</td>
</tr>
<tr>
<td class="left border-right-single">B</td>
<td class="left">Pink</td>
</tr>
<tr>
<td class="left border-bottom-single border-right-single">AB</td>
<td class="left border-bottom-single">White</td>
</tr>
</tbody>
</table></div>
</div>
</div>
<div id="p-606.121(d)(4)">
<p class="indent-2" data-title="606.121(d)(4)"><span class="paragraph-hierarchy"><span class="paren">(</span>4<span class="paren">)</span></span> Special labels, such as those described in <a href="/current/title-21/section-606.121#p-606.121(h)" class="cfr external">paragraphs (h)</a> and <a href="/current/title-21/section-606.121#p-606.121(i)" class="cfr external">(i)</a> of this section, may be color-coded.</p>
</div>
</div>
<div id="p-606.121(e)">
<p class="indent-1" data-title="606.121(e)"><span class="paragraph-hierarchy"><span class="paren">(</span>e<span class="paren">)</span></span> Container label requirements for particular products or groups of products.</p>
<div id="p-606.121(e)(1)">
<p class="indent-2" data-title="606.121(e)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> Whole Blood labels must include:</p>
<div id="p-606.121(e)(1)(i)">
<p class="indent-3" data-title="606.121(e)(1)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> The name of the applicable anticoagulant approved for use by the Director, CBER.</p>
</div>
<div id="p-606.121(e)(1)(ii)">
<p class="indent-3" data-title="606.121(e)(1)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> The volume of anticoagulant.</p>
</div>
<div id="p-606.121(e)(1)(iii)">
<p class="indent-3" data-title="606.121(e)(1)(iii)"><span class="paragraph-hierarchy"><span class="paren">(</span>iii<span class="paren">)</span></span> If tests for unexpected antibodies are positive, blood intended for transfusion must be labeled: “Contains (name of antibody).”</p>
</div>
</div>
<div id="p-606.121(e)(2)">
<p class="indent-2" data-title="606.121(e)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> Except for frozen, deglycerolized, or washed Red Blood Cell products, Red Blood Cell labels must include:</p>
<div id="p-606.121(e)(2)(i)">
<p class="indent-3" data-title="606.121(e)(2)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> The type of anticoagulant, and if applicable, the volume of Whole Blood and type of additive solution, with which the product was prepared.</p>
</div>
<div id="p-606.121(e)(2)(ii)">
<p class="indent-3" data-title="606.121(e)(2)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> If tests for unexpected antibodies are positive and the product is intended for transfusion, the statement: “Contains (name of antibody).”</p>
</div>
</div>
<div id="p-606.121(e)(3)">
<p class="indent-2" data-title="606.121(e)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> If tests for unexpected antibodies are positive, Plasma intended for transfusion must be labeled: “Contains (name of antibody).”</p>
</div>
<div id="p-606.121(e)(4)">
<p class="indent-2" data-title="606.121(e)(4)"><span class="paragraph-hierarchy"><span class="paren">(</span>4<span class="paren">)</span></span> Recovered plasma labels must include:</p>
<div id="p-606.121(e)(4)(i)">
<p class="indent-3" data-title="606.121(e)(4)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> In lieu of an expiration date, the date of collection of the oldest material in the container.</p>
</div>
<div id="p-606.121(e)(4)(ii)">
<p class="indent-3" data-title="606.121(e)(4)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> For recovered plasma not meeting the requirements for manufacture into licensable products, the statement: “Not for Use in Products Subject to License Under Section 351 of the Public Health Service Act.”</p>
</div>
<div id="p-606.121(e)(4)(iii)">
<p class="indent-3" data-title="606.121(e)(4)(iii)"><span class="paragraph-hierarchy"><span class="paren">(</span>iii<span class="paren">)</span></span> The type of anticoagulant with which the product was prepared.</p>
</div>
</div>
<div id="p-606.121(e)(5)">
<p class="indent-2" data-title="606.121(e)(5)"><span class="paragraph-hierarchy"><span class="paren">(</span>5<span class="paren">)</span></span> Source Plasma labels must include the following information:</p>
<div id="p-606.121(e)(5)(i)">
<p class="indent-3" data-title="606.121(e)(5)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> The cautionary statement, as specified in <a href="/current/title-21/section-606.121#p-606.121(c)(10)" class="cfr external">paragraph (c)(10)</a> of this section, must follow the proper name with any appropriate modifiers and attributes and be of similar prominence as the proper name.</p>
</div>
<div id="p-606.121(e)(5)(ii)">
<p class="indent-3" data-title="606.121(e)(5)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> The statement “Store at −20 °C or colder,” provided, that where plasma is intended for manufacturing into noninjectable products, this statement may be replaced by a statement of the temperature appropriate for manufacture of the final product to be prepared from the plasma.</p>
</div>
<div id="p-606.121(e)(5)(iii)">
<p class="indent-3" data-title="606.121(e)(5)(iii)"><span class="paragraph-hierarchy"><span class="paren">(</span>iii<span class="paren">)</span></span> The total volume or weight of plasma and total quantity and type of anticoagulant used.</p>
</div>
<div id="p-606.121(e)(5)(iv)">
<p class="indent-3" data-title="606.121(e)(5)(iv)"><span class="paragraph-hierarchy"><span class="paren">(</span>iv<span class="paren">)</span></span> When plasma collected from a donor is reactive for a serologic test for syphilis, a statement that the plasma is reactive and must be used only for the manufacturing of positive control reagents for the serologic test for syphilis.</p>
</div>
<div id="p-606.121(e)(5)(v)">
<p class="indent-3" data-title="606.121(e)(5)(v)"><span class="paragraph-hierarchy"><span class="paren">(</span>v<span class="paren">)</span></span> Source Plasma diverted for Source Plasma Salvaged must be relabeled “Source Plasma Salvaged” as prescribed in <a href="/current/title-21/section-640.76" class="cfr external">§ 640.76 of this chapter</a>. Immediately following the proper name of the product, with any appropriate modifiers and attributes, the labeling must prominently state as applicable, “STORAGE TEMPERATURE EXCEEDED −20 °C” or “SHIPPING TEMPERATURE EXCEEDED −5 °C.”</p>
</div>
<div id="p-606.121(e)(5)(vi)">
<p class="indent-3" data-title="606.121(e)(5)(vi)"><span class="paragraph-hierarchy"><span class="paren">(</span>vi<span class="paren">)</span></span> A statement as to whether the plasma was collected from normal donors, or from donors in specific collection programs approved by the Director, CBER. In the case of specific collection programs, the label must state the defining characteristics of the plasma. In the case of immunized donors, the label must state the immunizing antigen.</p>
</div>
</div>
</div>
<div id="p-606.121(f)">
<p class="indent-1" data-title="606.121(f)"><span class="paragraph-hierarchy"><span class="paren">(</span>f<span class="paren">)</span></span> Blood and blood components determined to be unsuitable for transfusion must be prominently labeled “NOT FOR TRANSFUSION,” and the label must state the reason the unit is considered unsuitable. The provision does not apply to blood and blood components intended solely for further manufacture.</p>
</div>
<div id="p-606.121(g)">
<p class="indent-1" data-title="606.121(g)"><span class="paragraph-hierarchy"><span class="paren">(</span>g<span class="paren">)</span></span> [Reserved]</p>
</div>
<div id="p-606.121(h)">
<p class="indent-1" data-title="606.121(h)"><span class="paragraph-hierarchy"><span class="paren">(</span>h<span class="paren">)</span></span> The following additional information must appear on the label for blood and blood components shipped in an emergency prior to completion of required tests, in accordance with <a href="/current/title-21/section-610.40#p-610.40(g)" class="cfr external">§ 610.40(g) of this chapter</a>:</p>
<div id="p-606.121(h)(1)">
<p class="indent-2" data-title="606.121(h)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> The statement: “FOR EMERGENCY USE ONLY BY __ .”</p>
</div>
<div id="p-606.121(h)(2)">
<p class="indent-2" data-title="606.121(h)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> Results of any tests prescribed under <a href="/current/title-21/section-610.40" class="cfr external">§§ 610.40</a> and <a href="/current/title-21/section-640.5#p-640.5(b)" class="cfr external">640.5(b)</a> or <a href="/current/title-21/section-640.5#p-640.5(c)" class="cfr external">(c) of this chapter</a> completed before shipment.</p>
</div>
<div id="p-606.121(h)(3)">
<p class="indent-2" data-title="606.121(h)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> Indication of any tests prescribed under <a href="/current/title-21/section-610.40" class="cfr external">§§ 610.40</a> and <a href="/current/title-21/section-640.5#p-640.5(b)" class="cfr external">640.5(b)</a> or <a href="/current/title-21/section-640.5#p-640.5(c)" class="cfr external">(c) of this chapter</a> not completed before shipment.</p>
</div>
</div>
<div id="p-606.121(i)">
<p class="indent-1" data-title="606.121(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> The following additional information must appear on the label for blood and blood components intended for autologous transfusion:</p>
<div id="p-606.121(i)(1)">
<p class="indent-2" data-title="606.121(i)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> Information adequately identifying the patient, <em>e.g.,</em> name, date of birth, hospital, and identification number.</p>
</div>
<div id="p-606.121(i)(2)">
<p class="indent-2" data-title="606.121(i)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> Date of donation.</p>
</div>
<div id="p-606.121(i)(3)">
<p class="indent-2" data-title="606.121(i)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> The statement: “AUTOLOGOUS DONOR.”</p>
</div>
<div id="p-606.121(i)(4)">
<p class="indent-2" data-title="606.121(i)(4)"><span class="paragraph-hierarchy"><span class="paren">(</span>4<span class="paren">)</span></span> The ABO and Rh blood group and type, except as provided in <a href="/current/title-21/section-606.121#p-606.121(c)(9)" class="cfr external">paragraph (c)(9)</a> of this section.</p>
</div>
<div id="p-606.121(i)(5)">
<p class="indent-2" data-title="606.121(i)(5)"><span class="paragraph-hierarchy"><span class="paren">(</span>5<span class="paren">)</span></span> Each container of blood and blood component intended for autologous use and obtained from a donor who fails to meet any of the donor eligibility requirements under <a href="/current/title-21/section-630.10" class="cfr external">§ 630.10 of this chapter</a> or who is reactive to or positive for one or more tests for evidence of infection due to relevant transfusion-transmitted infections under <a href="/current/title-21/section-610.40" class="cfr external">§ 610.40 of this chapter</a> must be prominently and permanently labeled “FOR AUTOLOGOUS USE ONLY” and as otherwise required under <a href="/current/title-21/section-610.40" class="cfr external">§ 610.40 of this chapter</a>. Such units also may have the ABO and Rh blood group and type on the label.</p>
</div>
<div id="p-606.121(i)(6)">
<p class="indent-2" data-title="606.121(i)(6)"><span class="paragraph-hierarchy"><span class="paren">(</span>6<span class="paren">)</span></span> Units of blood and blood components originally intended for autologous use, except those labeled as prescribed under <a href="/current/title-21/section-606.121#p-606.121(i)(5)" class="cfr external">paragraph (i)(5)</a> of this section, may be issued for allogeneic transfusion provided the container label complies with all applicable provisions of <a href="/current/title-21/section-606.121#p-606.121(b)" class="cfr external">paragraphs (b)</a> through <a href="/current/title-21/section-606.121#p-606.121(e)" class="cfr external">(e)</a> of this section. In such case, the special label required under <a href="/current/title-21/section-606.121#p-606.121(i)(1)" class="cfr external">paragraphs (i)(1)</a>, <a href="/current/title-21/section-606.121#p-606.121(i)(2)" class="cfr external">(i)(2)</a>, and <a href="/current/title-21/section-606.121#p-606.121(i)(3)" class="cfr external">(i)(3)</a> of this section must be removed or otherwise obscured.</p>
</div>
</div>
<div id="p-606.121(j)"><p class="indent-1" data-title="606.121(j)"><span class="paragraph-hierarchy"><span class="paren">(</span>j<span class="paren">)</span></span> A tie-tag attached to the container may be used for providing the information required by <a href="/current/title-21/section-606.121#p-606.121(e)(1)(iii)" class="cfr external">paragraphs (e)(1)(iii)</a>, <a href="/current/title-21/section-606.121#p-606.121(e)(2)(ii)" class="cfr external">(e)(2)(ii)</a>, and <a href="/current/title-21/section-606.121#p-606.121(e)(3)" class="cfr external">(e)(3)</a>, <a href="/current/title-21/section-606.121#p-606.121(h)" class="cfr external">(h)</a>, or <a href="/current/title-21/section-606.121#p-606.121(i)(1)" class="cfr external">(i)(1)</a>, <a href="/current/title-21/section-606.121#p-606.121(i)(2)" class="cfr external">(i)(2)</a>, and <a href="/current/title-21/section-606.121#p-606.121(i)(3)" class="cfr external">(i)(3)</a> of this section.</p></div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/77-FR-16" class="fr-reference" data-reference="77 FR 16">77 FR 16</a>, Jan. 3, 2012, as amended at <a href="https://www.federalregister.gov/citation/80-FR-29895" class="fr-reference" data-reference="80 FR 29895">80 FR 29895</a>, May 22, 2015]
</p>
</div>

<div class="section" id="606.122">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.122","citation":"21 CFR 606.122"}'>§ 606.122 Circular of information.</h4>
<p>A circular of information must be available for distribution if the product is intended for transfusion. The circular of information must provide adequate directions for use, including the following information:</p>
<div id="p-606.122(a)">
<p class="indent-1" data-title="606.122(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> Instructions to mix the product before use.</p>
</div>
<div id="p-606.122(b)">
<p class="indent-1" data-title="606.122(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> Instructions to use a filter in the administration equipment.</p>
</div>
<div id="p-606.122(c)">
<p class="indent-1" data-title="606.122(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> The statement “Do Not Add Medications” or an explanation concerning allowable additives.</p>
</div>
<div id="p-606.122(d)">
<p class="indent-1" data-title="606.122(d)"><span class="paragraph-hierarchy"><span class="paren">(</span>d<span class="paren">)</span></span> A description of the product, its source, and preparation, including the name and proportion of the anticoagulant used in collecting the Whole Blood from each product is prepared.</p>
</div>
<div id="p-606.122(e)">
<p class="indent-1" data-title="606.122(e)"><span class="paragraph-hierarchy"><span class="paren">(</span>e<span class="paren">)</span></span> A statement that the product was prepared from blood that was found negative when tested for relevant transfusion-transmitted infections, as required under <a href="/current/title-21/section-610.40" class="cfr external">§ 610.40 of this chapter</a> (include each test that was performed).</p>
</div>
<div id="p-606.122(f)">
<p class="indent-1" data-title="606.122(f)"><span class="paragraph-hierarchy"><span class="paren">(</span>f<span class="paren">)</span></span> The statement: “Warning: The risk of transmitting infectious agents is present. Careful donor selection and available laboratory tests do not eliminate the hazard.”</p>
</div>
<div id="p-606.122(g)">
<p class="indent-1" data-title="606.122(g)"><span class="paragraph-hierarchy"><span class="paren">(</span>g<span class="paren">)</span></span> The names of cryoprotective agents and other additives that may still be present in the product.</p>
</div>
<div id="p-606.122(h)">
<p class="indent-1" data-title="606.122(h)"><span class="paragraph-hierarchy"><span class="paren">(</span>h<span class="paren">)</span></span> The names and results of all tests performed when necessary for safe and effective use.</p>
</div>
<div id="p-606.122(i)">
<p class="indent-1" data-title="606.122(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> The use of the product, indications, contradications, side effects and hazards, dosage and administration recommendations.</p>
</div>
<div id="p-606.122(j)">
<p class="indent-1" data-title="606.122(j)"><span class="paragraph-hierarchy"><span class="paren">(</span>j<span class="paren">)</span></span> [Reserved]</p>
</div>
<div id="p-606.122(k)">
<p class="indent-1" data-title="606.122(k)"><span class="paragraph-hierarchy"><span class="paren">(</span>k<span class="paren">)</span></span> For Red Blood Cells, the circular of information must contain:</p>
<div id="p-606.122(k)(1)">
<p class="indent-2" data-title="606.122(k)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> Instructions to administer a suitable plasma volume expander if Red Blood Cells are substituted when Whole Blood is the indicated product.</p>
</div>
<div id="p-606.122(k)(2)">
<p class="indent-2" data-title="606.122(k)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> A warning not to add Lactated Ringer's Injection U.S.P. solution to Red Blood Cell products.</p>
</div>
</div>
<div id="p-606.122(l)">
<p class="indent-1" data-title="606.122(l)"><span class="paragraph-hierarchy"><span class="paren">(</span>l<span class="paren">)</span></span> For Platelets, the circular of information must contain:</p>
<div id="p-606.122(l)(1)">
<p class="indent-2" data-title="606.122(l)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> The approximate volume of plasma from which a sample unit of Platelets is prepared.</p>
</div>
<div id="p-606.122(l)(2)">
<p class="indent-2" data-title="606.122(l)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> Instructions to begin administration as soon as possible, but not more than 4 hours after entering the container.</p>
</div>
</div>
<div id="p-606.122(m)">
<p class="indent-1" data-title="606.122(m)"><span class="paragraph-hierarchy"><span class="paren">(</span>m<span class="paren">)</span></span> For Plasma, the circular of information must contain:</p>
<div id="p-606.122(m)(1)">
<p class="indent-2" data-title="606.122(m)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> A warning against further processing of the frozen product if there is evidence of breakage or thawing.</p>
</div>
<div id="p-606.122(m)(2)">
<p class="indent-2" data-title="606.122(m)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> Instructions to thaw the frozen product at a temperature appropriate for the product.</p>
</div>
<div id="p-606.122(m)(3)">
<p class="indent-2" data-title="606.122(m)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> When applicable, instructions to begin administration of the product within a specified time after thawing.</p>
</div>
<div id="p-606.122(m)(4)">
<p class="indent-2" data-title="606.122(m)(4)"><span class="paragraph-hierarchy"><span class="paren">(</span>4<span class="paren">)</span></span> Instructions to administer to ABO-group-compatible recipients.</p>
</div>
<div id="p-606.122(m)(5)">
<p class="indent-2" data-title="606.122(m)(5)"><span class="paragraph-hierarchy"><span class="paren">(</span>5<span class="paren">)</span></span> A statement that this product has the same risk of transmitting infectious agents as Whole Blood; other plasma volume expanders without this risk are available for treating hypovolemia.</p>
</div>
</div>
<div id="p-606.122(n)">
<p class="indent-1" data-title="606.122(n)"><span class="paragraph-hierarchy"><span class="paren">(</span>n<span class="paren">)</span></span> For Cryoprecipitated AHF, the circular of information must contain:</p>
<div id="p-606.122(n)(1)">
<p class="indent-2" data-title="606.122(n)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> A statement that the average potency is 80 or more International Units of antihemophilic factor.</p>
</div>
<div id="p-606.122(n)(2)">
<p class="indent-2" data-title="606.122(n)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> The statement: “Usually contains at least 150 milligrams of fibrinogen”; or, alternatively, the average fibrinogen level determined by assay of representative units.</p>
</div>
<div id="p-606.122(n)(3)">
<p class="indent-2" data-title="606.122(n)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> A warning against further processing of the product if there is evidence of breakage or thawing.</p>
</div>
<div id="p-606.122(n)(4)">
<p class="indent-2" data-title="606.122(n)(4)"><span class="paragraph-hierarchy"><span class="paren">(</span>4<span class="paren">)</span></span> Instructions to thaw the product for no more than 15 minutes at a temperature of between 30 and 37 °C.</p>
</div>
<div id="p-606.122(n)(5)">
<p class="indent-2" data-title="606.122(n)(5)"><span class="paragraph-hierarchy"><span class="paren">(</span>5<span class="paren">)</span></span> Instructions to store at room temperature after thawing and to begin administration as soon as possible but no more than 4 hours after entering the container or after pooling and within 6 hours after thawing.</p>
</div>
<div id="p-606.122(n)(6)">
<p class="indent-2" data-title="606.122(n)(6)"><span class="paragraph-hierarchy"><span class="paren">(</span>6<span class="paren">)</span></span> A statement that 0.9 percent Sodium Chloride Injection U.S.P. is the preferred diluent.</p>
</div>
<div id="p-606.122(n)(7)">
<p class="indent-2" data-title="606.122(n)(7)"><span class="paragraph-hierarchy"><span class="paren">(</span>7<span class="paren">)</span></span> Adequate instructions for pooling to ensure complete removal of all concentrated material from each container.</p>
</div>
<div id="p-606.122(n)(8)"><p class="indent-2" data-title="606.122(n)(8)"><span class="paragraph-hierarchy"><span class="paren">(</span>8<span class="paren">)</span></span> The statement: “Good patient management requires monitoring treatment responses to Cryoprecipitated AHF transfusions with periodic plasma factor VIII or fibrinogen assays in hemophilia A and hypofibrinogenemic recipients, respectively.”</p></div>
</div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/50-FR-35470" class="fr-reference" data-reference="50 FR 35470">50 FR 35470</a>, Aug. 30, 1985, as amended at <a href="https://www.federalregister.gov/citation/53-FR-116" class="fr-reference" data-reference="53 FR 116">53 FR 116</a>, Jan. 5, 1988; <a href="https://www.federalregister.gov/citation/64-FR-45371" class="fr-reference" data-reference="64 FR 45371">64 FR 45371</a>, Aug. 19, 1999; <a href="https://www.federalregister.gov/citation/77-FR-18" class="fr-reference" data-reference="77 FR 18">77 FR 18</a>, Jan. 3, 2012; <a href="https://www.federalregister.gov/citation/80-FR-29895" class="fr-reference" data-reference="80 FR 29895">80 FR 29895</a>, May 22, 2015]
</p>
</div>

</div>

<div class="subpart" id="subpart-H"><h2 data-hierarchy-metadata="{&quot;path&quot;:&quot;/current/title-21/part-606/subpart-H&quot;,&quot;citation&quot;:&quot;21 CFR Part 606 Subpart H&quot;}">Subpart H—Laboratory Controls</h2>
<div class="section" id="606.140">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.140","citation":"21 CFR 606.140"}'>§ 606.140 Laboratory controls.</h4>
<p>Laboratory control procedures shall include:</p>
<div id="p-606.140(a)">
<p class="indent-1" data-title="606.140(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> The establishment of scientifically sound and appropriate specifications, standards and test procedures to assure that blood and blood components are safe, pure, potent and effective.</p>
</div>
<div id="p-606.140(b)">
<p class="indent-1" data-title="606.140(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> Adequate provisions for monitoring the reliability, accuracy, precision and performance of laboratory test procedures and instruments.</p>
</div>
<div id="p-606.140(c)"><p class="indent-1" data-title="606.140(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> Adequate identification and handling of all test samples so that they are accurately related to the specific unit of product being tested, or to its donor, or to the specific recipient, where applicable.</p></div>
</div>

<div class="section" id="606.145">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.145","citation":"21 CFR 606.145"}'>§ 606.145 Control of bacterial contamination of platelets.</h4>
<div id="p-606.145(a)">
<p class="indent-1" data-title="606.145(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> Blood collection establishments and transfusion services must assure that the risk of bacterial contamination of platelets is adequately controlled using FDA approved or cleared devices or other adequate and appropriate methods found acceptable for this purpose by FDA.</p>
</div>
<div id="p-606.145(b)">
<p class="indent-1" data-title="606.145(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> In the event that a blood collection establishment identifies platelets as bacterially contaminated, that establishment must not release for transfusion the product or any other component prepared from the same collection, and must take appropriate steps to identify the organism.</p>
</div>
<div id="p-606.145(c)">
<p class="indent-1" data-title="606.145(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> In the event that a transfusion service identifies platelets as bacterially contaminated, the transfusion service must not release the product and must notify the blood collection establishment that provided the platelets. The transfusion service must take appropriate steps to identify the organism; these steps may include contracting with the collection establishment or a laboratory to identify the organism. The transfusion service must further notify the blood collection establishment either by providing information about the species of the contaminating organism when the transfusion service has been able to identify it, or by advising the blood collection establishment when the transfusion service has determined that the species cannot be identified.</p>
</div>
<div id="p-606.145(d)"><p class="indent-1" data-title="606.145(d)"><span class="paragraph-hierarchy"><span class="paren">(</span>d<span class="paren">)</span></span> In the event that a contaminating organism is identified under <a href="/current/title-21/section-606.145#p-606.145(b)" class="cfr external">paragraph (b)</a> or <a href="/current/title-21/section-606.145#p-606.145(c)" class="cfr external">(c)</a> of this section, the collection establishment's responsible physician, as defined in <a href="/current/title-21/section-630.3#p-630.3(i)" class="cfr external">§ 630.3(i) of this chapter</a>, must determine whether the contaminating organism is likely to be associated with a bacterial infection that is endogenous to the bloodstream of the donor, in accordance with a standard operating procedure developed under <a href="/current/title-21/section-606.100#p-606.100(b)(22)" class="cfr external">§ 606.100(b)(22)</a>. This determination may not be further delegated.</p></div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/80-FR-29895" class="fr-reference" data-reference="80 FR 29895">80 FR 29895</a>, May 22, 2015]
</p>
</div>

<div class="section" id="606.151">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.151","citation":"21 CFR 606.151"}'>§ 606.151 Compatibility testing.</h4>
<p>Standard operating procedures for compatibility testing shall include the following:</p>
<div id="p-606.151(a)">
<p class="indent-1" data-title="606.151(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> A method of collecting and identifying the blood samples of recipients to ensure positive identification.</p>
</div>
<div id="p-606.151(b)">
<p class="indent-1" data-title="606.151(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> The use of fresh recipient serum or plasma samples less than 3 days old for all pretransfusion testing if the recipient has been pregnant or transfused within the previous 3 months.</p>
</div>
<div id="p-606.151(c)">
<p class="indent-1" data-title="606.151(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> Procedures to demonstrate incompatibility between the donor's cell type and the recipient's serum or plasma type.</p>
</div>
<div id="p-606.151(d)">
<p class="indent-1" data-title="606.151(d)"><span class="paragraph-hierarchy"><span class="paren">(</span>d<span class="paren">)</span></span> A provision that, if the unit of donor's blood has not been screened by a method that will demonstrate agglutinating, coating and hemolytic antibodies, the recipient's cells shall be tested with the donor's serum (minor crossmatch) by a method that will so demonstrate.</p>
</div>
<div id="p-606.151(e)"><p class="indent-1" data-title="606.151(e)"><span class="paragraph-hierarchy"><span class="paren">(</span>e<span class="paren">)</span></span> Procedures to expedite transfusion in life-threatening emergencies. Records of all such incidents shall be maintained, including complete documentation justifying the emergency action, which shall be signed by a physician.</p></div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/40-FR-53532" class="fr-reference" data-reference="40 FR 53532">40 FR 53532</a>, Nov. 18, 1975, as amended at <a href="https://www.federalregister.gov/citation/64-FR-45371" class="fr-reference" data-reference="64 FR 45371">64 FR 45371</a>, Aug. 19, 1999; <a href="https://www.federalregister.gov/citation/66-FR-1835" class="fr-reference" data-reference="66 FR 1835">66 FR 1835</a>, Jan. 10, 2001; <a href="https://www.federalregister.gov/citation/66-FR-40889" class="fr-reference" data-reference="66 FR 40889">66 FR 40889</a>, Aug. 6, 2001]
</p>
</div>

</div>

<div class="subpart" id="subpart-I"><h2 data-hierarchy-metadata="{&quot;path&quot;:&quot;/current/title-21/part-606/subpart-I&quot;,&quot;citation&quot;:&quot;21 CFR Part 606 Subpart I&quot;}">Subpart I—Records and Reports</h2>
<div class="section" id="606.160">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.160","citation":"21 CFR 606.160"}'>§ 606.160 Records.</h4>
<div id="p-606.160(a)">
<p class="indent-1" data-title="606.160(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> </p>
<div id="p-606.160(a)(1)">
<p class="indent-2" data-title="606.160(a)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> Records shall be maintained concurrently with the performance of each significant step in the collection, processing, compatibility testing, storage and distribution of each unit of blood and blood components so that all steps can be clearly traced. All records shall be legible and indelible, and shall identify the person performing the work, include dates of the various entries, show test results as well as the interpretation of the results, show the expiration date assigned to specific products, and be as detailed as necessary to provide a complete history of the work performed.</p>
</div>
<div id="p-606.160(a)(2)">
<p class="indent-2" data-title="606.160(a)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> Appropriate records shall be available from which to determine lot numbers of supplies and reagents used for specific lots or units of the final product.</p>
</div>
</div>
<div id="p-606.160(b)">
<p class="indent-1" data-title="606.160(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> Records shall be maintained that include, but are not limited to, the following when applicable:</p>
<div id="p-606.160(b)(1)">
<p class="indent-2" data-title="606.160(b)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> Donor records:</p>
<div id="p-606.160(b)(1)(i)">
<p class="indent-3" data-title="606.160(b)(1)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> Donor selection, including medical interview and examination and where applicable, informed consent.</p>
</div>
<div id="p-606.160(b)(1)(ii)">
<p class="indent-3" data-title="606.160(b)(1)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> Permanent and temporary deferrals for health reasons including reason(s) for deferral.</p>
</div>
<div id="p-606.160(b)(1)(iii)">
<p class="indent-3" data-title="606.160(b)(1)(iii)"><span class="paragraph-hierarchy"><span class="paren">(</span>iii<span class="paren">)</span></span> Donor adverse reaction complaints and reports, including results of all investigations and followup.</p>
</div>
<div id="p-606.160(b)(1)(iv)">
<p class="indent-3" data-title="606.160(b)(1)(iv)"><span class="paragraph-hierarchy"><span class="paren">(</span>iv<span class="paren">)</span></span> Therapeutic bleedings, including signed requests from attending physicians, the donor's disease and disposition of units.</p>
</div>
<div id="p-606.160(b)(1)(v)">
<p class="indent-3" data-title="606.160(b)(1)(v)"><span class="paragraph-hierarchy"><span class="paren">(</span>v<span class="paren">)</span></span> Immunization, including informed consent, identification of the antigen, dosage and route of administration.</p>
</div>
<div id="p-606.160(b)(1)(vi)">
<p class="indent-3" data-title="606.160(b)(1)(vi)"><span class="paragraph-hierarchy"><span class="paren">(</span>vi<span class="paren">)</span></span> Blood collection, including identification of the phlebotomist.</p>
</div>
<div id="p-606.160(b)(1)(vii)">
<p class="indent-3" data-title="606.160(b)(1)(vii)"><span class="paragraph-hierarchy"><span class="paren">(</span>vii<span class="paren">)</span></span> Records to relate the donor with the unit number of each previous donation from that donor.</p>
</div>
<div id="p-606.160(b)(1)(viii)">
<p class="indent-3" data-title="606.160(b)(1)(viii)"><span class="paragraph-hierarchy"><span class="paren">(</span>viii<span class="paren">)</span></span> Records concerning the following activities performed under <a href="/current/title-21/section-610.46" class="cfr external">§§ 610.46</a> and <a href="/current/title-21/section-610.47" class="cfr external">610.47 of this chapter</a>: Quarantine; consignee notification; testing; notification of a transfusion recipient, the recipient's physician of record, or the recipient's legal representative; and disposition.</p>
</div>
<div id="p-606.160(b)(1)(ix)">
<p class="indent-3" data-title="606.160(b)(1)(ix)"><span class="paragraph-hierarchy"><span class="paren">(</span>ix<span class="paren">)</span></span> The donor's postal address provided at the time of donation where the donor may be contacted within 8 weeks after donation.</p>
</div>
<div id="p-606.160(b)(1)(x)">
<p class="indent-3" data-title="606.160(b)(1)(x)"><span class="paragraph-hierarchy"><span class="paren">(</span>x<span class="paren">)</span></span> Records of notification of donors deferred or determined not to be eligible for donation, including appropriate followup if the initial attempt at notification fails, performed under <a href="/current/title-21/section-630.40" class="cfr external">§ 630.40 of this chapter</a>.</p>
</div>
<div id="p-606.160(b)(1)(xi)">
<p class="indent-3" data-title="606.160(b)(1)(xi)"><span class="paragraph-hierarchy"><span class="paren">(</span>xi<span class="paren">)</span></span> Records of notification of the referring physician of a deferred autologous donor, including appropriate followup if the initial attempt at notification fails, performed under <a href="/current/title-21/section-630.40" class="cfr external">§ 630.40 of this chapter</a>.</p>
</div>
</div>
<div id="p-606.160(b)(2)">
<p class="indent-2" data-title="606.160(b)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> Processing records:</p>
<div id="p-606.160(b)(2)(i)">
<p class="indent-3" data-title="606.160(b)(2)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> Blood processing, including results and interpretation of all tests and retests.</p>
</div>
<div id="p-606.160(b)(2)(ii)">
<p class="indent-3" data-title="606.160(b)(2)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> Component preparation, including all relevant dates and times.</p>
</div>
<div id="p-606.160(b)(2)(iii)">
<p class="indent-3" data-title="606.160(b)(2)(iii)"><span class="paragraph-hierarchy"><span class="paren">(</span>iii<span class="paren">)</span></span> Separation and pooling of recovered plasma.</p>
</div>
<div id="p-606.160(b)(2)(iv)">
<p class="indent-3" data-title="606.160(b)(2)(iv)"><span class="paragraph-hierarchy"><span class="paren">(</span>iv<span class="paren">)</span></span> Centrifugation and pooling of source plasma.</p>
</div>
<div id="p-606.160(b)(2)(v)">
<p class="indent-3" data-title="606.160(b)(2)(v)"><span class="paragraph-hierarchy"><span class="paren">(</span>v<span class="paren">)</span></span> Labeling, including initials of the person(s) performing the procedure.</p>
</div>
</div>
<div id="p-606.160(b)(3)">
<p class="indent-2" data-title="606.160(b)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> Storage and distribution records:</p>
<div id="p-606.160(b)(3)(i)">
<p class="indent-3" data-title="606.160(b)(3)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> Distribution and disposition, as appropriate, of blood and blood products.</p>
</div>
<div id="p-606.160(b)(3)(ii)">
<p class="indent-3" data-title="606.160(b)(3)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> Visual inspection of whole blood and red blood cells during storage and immediately before distribution.</p>
</div>
<div id="p-606.160(b)(3)(iii)">
<p class="indent-3" data-title="606.160(b)(3)(iii)"><span class="paragraph-hierarchy"><span class="paren">(</span>iii<span class="paren">)</span></span> Storage temperature, including initialed temperature recorder charts.</p>
</div>
<div id="p-606.160(b)(3)(iv)">
<p class="indent-3" data-title="606.160(b)(3)(iv)"><span class="paragraph-hierarchy"><span class="paren">(</span>iv<span class="paren">)</span></span> Reissue, including records of proper temperature maintenance.</p>
</div>
<div id="p-606.160(b)(3)(v)">
<p class="indent-3" data-title="606.160(b)(3)(v)"><span class="paragraph-hierarchy"><span class="paren">(</span>v<span class="paren">)</span></span> Emergency release of blood, including signature of requesting physician obtained before or after release.</p>
</div>
</div>
<div id="p-606.160(b)(4)">
<p class="indent-2" data-title="606.160(b)(4)"><span class="paragraph-hierarchy"><span class="paren">(</span>4<span class="paren">)</span></span> Compatibility test records:</p>
<div id="p-606.160(b)(4)(i)">
<p class="indent-3" data-title="606.160(b)(4)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> Results of all compatibility tests, including crossmatching, testing of patient samples, antibody screening and identification.</p>
</div>
<div id="p-606.160(b)(4)(ii)">
<p class="indent-3" data-title="606.160(b)(4)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> Results of confirmatory testing.</p>
</div>
</div>
<div id="p-606.160(b)(5)">
<p class="indent-2" data-title="606.160(b)(5)"><span class="paragraph-hierarchy"><span class="paren">(</span>5<span class="paren">)</span></span> Quality control records:</p>
<div id="p-606.160(b)(5)(i)">
<p class="indent-3" data-title="606.160(b)(5)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> Calibration and standardization of equipment.</p>
</div>
<div id="p-606.160(b)(5)(ii)">
<p class="indent-3" data-title="606.160(b)(5)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> Performance checks of equipment and reagents.</p>
</div>
<div id="p-606.160(b)(5)(iii)">
<p class="indent-3" data-title="606.160(b)(5)(iii)"><span class="paragraph-hierarchy"><span class="paren">(</span>iii<span class="paren">)</span></span> Periodic check on sterile technique.</p>
</div>
<div id="p-606.160(b)(5)(iv)">
<p class="indent-3" data-title="606.160(b)(5)(iv)"><span class="paragraph-hierarchy"><span class="paren">(</span>iv<span class="paren">)</span></span> Periodic tests of capacity of shipping containers to maintain proper temperature in transit.</p>
</div>
<div id="p-606.160(b)(5)(v)">
<p class="indent-3" data-title="606.160(b)(5)(v)"><span class="paragraph-hierarchy"><span class="paren">(</span>v<span class="paren">)</span></span> Proficiency test results.</p>
</div>
</div>
<div id="p-606.160(b)(6)">
<p class="indent-2" data-title="606.160(b)(6)"><span class="paragraph-hierarchy"><span class="paren">(</span>6<span class="paren">)</span></span> Transfusion reaction reports and complaints, including records of investigations and followup.</p>
</div>
<div id="p-606.160(b)(7)">
<p class="indent-2" data-title="606.160(b)(7)"><span class="paragraph-hierarchy"><span class="paren">(</span>7<span class="paren">)</span></span> General records:</p>
<div id="p-606.160(b)(7)(i)">
<p class="indent-3" data-title="606.160(b)(7)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> Sterilization of supplies and reagents prepared within the facility, including date, time interval, temperature and mode.</p>
</div>
<div id="p-606.160(b)(7)(ii)">
<p class="indent-3" data-title="606.160(b)(7)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> Responsible personnel.</p>
</div>
<div id="p-606.160(b)(7)(iii)">
<p class="indent-3" data-title="606.160(b)(7)(iii)"><span class="paragraph-hierarchy"><span class="paren">(</span>iii<span class="paren">)</span></span> Biological product deviations.</p>
</div>
<div id="p-606.160(b)(7)(iv)">
<p class="indent-3" data-title="606.160(b)(7)(iv)"><span class="paragraph-hierarchy"><span class="paren">(</span>iv<span class="paren">)</span></span> Maintenance records for equipment and general physical plant.</p>
</div>
<div id="p-606.160(b)(7)(v)">
<p class="indent-3" data-title="606.160(b)(7)(v)"><span class="paragraph-hierarchy"><span class="paren">(</span>v<span class="paren">)</span></span> Supplies and reagents, including name of manufacturer or supplier, lot numbers, expiration date and date of receipt.</p>
</div>
<div id="p-606.160(b)(7)(vi)">
<p class="indent-3" data-title="606.160(b)(7)(vi)"><span class="paragraph-hierarchy"><span class="paren">(</span>vi<span class="paren">)</span></span> Disposition of rejected supplies and reagents used in the collection, processing and compatibility testing of blood and blood components.</p>
</div>
</div>
</div>
<div id="p-606.160(c)">
<p class="indent-1" data-title="606.160(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> A donor number shall be assigned to each accepted donor, which relates the unit of blood collected to that donor, to his medical record, to any component or blood product from that donor's unit of blood, and to all records describing the history and ultimate disposition of these products.</p>
</div>
<div id="p-606.160(d)">
<p class="indent-1" data-title="606.160(d)"><span class="paragraph-hierarchy"><span class="paren">(</span>d<span class="paren">)</span></span> Records shall be retained for such interval beyond the expiration date for the blood or blood component as necessary to facilitate the reporting of any unfavorable clinical reactions. You must retain individual product records no less than 10 years after the records of processing are completed or 6 months after the latest expiration date for the individual product, whichever is the later date. When there is no expiration date, records shall be retained indefinitely.</p>
</div>
<div id="p-606.160(e)">
<p class="indent-1" data-title="606.160(e)"><span class="paragraph-hierarchy"><span class="paren">(</span>e<span class="paren">)</span></span> <em class="paragraph-heading">Records of deferred donors.</em> </p>
<div id="p-606.160(e)(1)">
<p class="indent-2" data-title="606.160(e)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> Establishments must maintain at each location a record of all donors found to be ineligible or deferred at that location so that blood and blood components from an ineligible donor are not collected and/or released while the donor is ineligible or deferred; and</p>
</div>
<div id="p-606.160(e)(2)">
<p class="indent-2" data-title="606.160(e)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> Establishments must maintain at all locations operating under the same license or under common management a cumulative record of donors deferred from donation under <a href="/current/title-21/section-610.41" class="cfr external">§ 610.41 of this chapter</a> because their donation tested reactive under <a href="/current/title-21/section-610.40#p-610.40(a)(1)" class="cfr external">§ 610.40(a)(1) of this chapter</a> for evidence of infection due to HIV, HBV, or HCV. In addition, establishments other than Source Plasma establishments must include in this cumulative record donors deferred from donation under <a href="/current/title-21/section-610.41" class="cfr external">§ 610.41 of this chapter</a> because their donation tested reactive under <a href="/current/title-21/section-610.40#p-610.40(a)(2)" class="cfr external">§ 610.40(a)(2) of this chapter</a> for evidence of infection due to HTLV or Chagas disease.</p>
</div>
<div id="p-606.160(e)(3)">
<p class="indent-2" data-title="606.160(e)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> The cumulative record described in <a href="/current/title-21/section-606.160#p-606.160(e)(2)" class="cfr external">paragraph (e)(2)</a> of this section must be updated at least monthly to add donors newly deferred under <a href="/current/title-21/section-610.41" class="cfr external">§ 610.41 of this chapter</a> due to reactive tests for evidence of infection due to HIV, HBV, or HCV, and, if applicable, HTLV or Chagas disease.</p>
</div>
<div id="p-606.160(e)(4)"><p class="indent-2" data-title="606.160(e)(4)"><span class="paragraph-hierarchy"><span class="paren">(</span>4<span class="paren">)</span></span> Establishments must revise the cumulative record described in <a href="/current/title-21/section-606.160#p-606.160(e)(2)" class="cfr external">paragraph (e)(2)</a> of this section to remove donors who have been requalified under <a href="/current/title-21/section-610.41#p-610.41(b)" class="cfr external">§ 610.41(b) of this chapter</a>.</p></div>
</div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/40-FR-53532" class="fr-reference" data-reference="40 FR 53532">40 FR 53532</a>, Nov. 18, 1975, as amended at <a href="https://www.federalregister.gov/citation/61-FR-47422" class="fr-reference" data-reference="61 FR 47422">61 FR 47422</a>, Sept. 9, 1996; <a href="https://www.federalregister.gov/citation/64-FR-45371" class="fr-reference" data-reference="64 FR 45371">64 FR 45371</a>, Aug. 19, 1999; <a href="https://www.federalregister.gov/citation/65-FR-66635" class="fr-reference" data-reference="65 FR 66635">65 FR 66635</a>, Nov. 7, 2000; <a href="https://www.federalregister.gov/citation/66-FR-31176" class="fr-reference" data-reference="66 FR 31176">66 FR 31176</a>, June 11, 2001; <a href="https://www.federalregister.gov/citation/72-FR-48798" class="fr-reference" data-reference="72 FR 48798">72 FR 48798</a>, Aug. 24, 2007; <a href="https://www.federalregister.gov/citation/80-FR-80651" class="fr-reference" data-reference="80 FR 80651">80 FR 80651</a>, Dec. 28, 2015; <a href="https://www.federalregister.gov/citation/80-FR-29895" class="fr-reference" data-reference="80 FR 29895">80 FR 29895</a>, May 22, 2015]
</p>
</div>

<div class="section" id="606.165">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.165","citation":"21 CFR 606.165"}'>§ 606.165 Distribution and receipt; procedures and records.</h4>
<div id="p-606.165(a)">
<p class="indent-1" data-title="606.165(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> Distribution and receipt procedures shall include a system by which the distribution or receipt of each unit can be readily determined to facilitate its recall, if necessary.</p>
</div>
<div id="p-606.165(b)">
<p class="indent-1" data-title="606.165(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> Distribution records shall contain information to readily facilitate the identification of the name and address of the consignee, the date and quantity delivered, the lot number of the unit(s), the date of expiration or the date of collection, whichever is applicable, or for crossmatched blood and blood components, the name of the recipient.</p>
</div>
<div id="p-606.165(c)"><p class="indent-1" data-title="606.165(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> Receipt records shall contain the name and address of the collecting facility, date received, donor or lot number assigned by the collecting facility and the date of expiration or the date of collection, whichever is applicable.</p></div>
</div>

<div class="section" id="606.170">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.170","citation":"21 CFR 606.170"}'>§ 606.170 Adverse reaction file.</h4>
<div id="p-606.170(a)">
<p class="indent-1" data-title="606.170(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> Records shall be maintained of any reports of complaints of adverse reactions regarding each unit of blood or blood product arising as a result of blood collection or transfusion. A thorough investigation of each reported adverse reaction shall be made. A written report of the investigation of adverse reactions, including conclusions and followup, shall be prepared and maintained as part of the record for that lot or unit of final product by the collecting or transfusing facility. When it is determined that the product was at fault in causing a transfusion reaction, copies of all such written reports shall be forwarded to and maintained by the manufacturer or collecting facility.</p>
</div>
<div id="p-606.170(b)"><p class="indent-1" data-title="606.170(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> When a complication of blood collection or transfusion is confirmed to be fatal, the Director, Office of Compliance and Biologics Quality, CBER, must be notified by telephone, facsimile, express mail, or electronically transmitted mail as soon as possible. A written report of the investigation must be submitted to the Director, Office of Compliance and Biologics Quality, CBER, by mail, facsimile, or electronically transmitted mail (for mailing address, see <a href="/current/title-21/section-600.2#p-600.2(a)" class="cfr external">§ 600.2(a) of this chapter</a>), within 7 days after the fatality by the collecting facility in the event of a donor reaction, or by the facility that performed the compatibility tests in the event of a transfusion reaction.</p></div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/40-FR-53532" class="fr-reference" data-reference="40 FR 53532">40 FR 53532</a>, Nov. 18, 1975, as amended at <a href="https://www.federalregister.gov/citation/49-FR-23833" class="fr-reference" data-reference="49 FR 23833">49 FR 23833</a>, June 8, 1984; <a href="https://www.federalregister.gov/citation/50-FR-35471" class="fr-reference" data-reference="50 FR 35471">50 FR 35471</a>, Aug. 30, 1985; <a href="https://www.federalregister.gov/citation/55-FR-11014" class="fr-reference" data-reference="55 FR 11014">55 FR 11014</a>, Mar. 26, 1990; <a href="https://www.federalregister.gov/citation/64-FR-45371" class="fr-reference" data-reference="64 FR 45371">64 FR 45371</a>, Aug. 19, 1999; <a href="https://www.federalregister.gov/citation/67-FR-9586" class="fr-reference" data-reference="67 FR 9586">67 FR 9586</a>, Mar. 4, 2002; <a href="https://www.federalregister.gov/citation/77-FR-18" class="fr-reference" data-reference="77 FR 18">77 FR 18</a>, Jan. 3, 2012; <a href="https://www.federalregister.gov/citation/80-FR-18092" class="fr-reference" data-reference="80 FR 18092">80 FR 18092</a>, Apr. 3, 2015]
</p>
</div>

<div class="section" id="606.171">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-606.171","citation":"21 CFR 606.171"}'>§ 606.171 Reporting of product deviations by licensed manufacturers, unlicensed registered blood establishments, and transfusion services.</h4>
<div id="p-606.171(a)">
<p class="indent-1" data-title="606.171(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> <em class="paragraph-heading">Who must report under this section?</em>  You, a licensed manufacturer of blood and blood components, including Source Plasma; an unlicensed registered blood establishment; or a transfusion service who had control over the product when the deviation occurred, must report under this section. If you arrange for another person to perform a manufacturing, holding, or distribution step, while the product is in your control, that step is performed under your control. You must establish, maintain, and follow a procedure for receiving information from that person on all deviations, complaints, and adverse events concerning the affected product.</p>
</div>
<div id="p-606.171(b)">
<p class="indent-1" data-title="606.171(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> <em class="paragraph-heading">What do I report under this section?</em>  You must report any event, and information relevant to the event, associated with the manufacturing, to include testing, processing, packing, labeling, or storage, or with the holding or distribution, of both licensed and unlicensed blood or blood components, including Source Plasma, if that event meets all the following criteria:</p>
<div id="p-606.171(b)(1)">
<p class="indent-2" data-title="606.171(b)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> Either:</p>
<div id="p-606.171(b)(1)(i)">
<p class="indent-3" data-title="606.171(b)(1)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> Represents a deviation from current good manufacturing practice, applicable regulations, applicable standards, or established specifications that may affect the safety, purity, or potency of that product; or</p>
</div>
<div id="p-606.171(b)(1)(ii)">
<p class="indent-3" data-title="606.171(b)(1)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> Represents an unexpected or unforeseeable event that may affect the safety, purity, or potency of that product; and</p>
</div>
</div>
<div id="p-606.171(b)(2)">
<p class="indent-2" data-title="606.171(b)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> Occurs in your facility or another facility under contract with you; and</p>
</div>
<div id="p-606.171(b)(3)">
<p class="indent-2" data-title="606.171(b)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> Involves distributed blood or blood components.</p>
</div>
</div>
<div id="p-606.171(c)">
<p class="indent-1" data-title="606.171(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> <em class="paragraph-heading">When do I report under this section?</em>  You should report a biological product deviation as soon as possible but you must report at a date not to exceed 45-calendar days from the date you, your agent, or another person who performs a manufacturing, holding, or distribution step under your control, acquire information reasonably suggesting that a reportable event has occurred.</p>
</div>
<div id="p-606.171(d)">
<p class="indent-1" data-title="606.171(d)"><span class="paragraph-hierarchy"><span class="paren">(</span>d<span class="paren">)</span></span> <em class="paragraph-heading">How do I report under this section?</em>  You must report on Form FDA-3486.</p>
</div>
<div id="p-606.171(e)">
<p class="indent-1" data-title="606.171(e)"><span class="paragraph-hierarchy"><span class="paren">(</span>e<span class="paren">)</span></span> <em class="paragraph-heading">Where do I report under this section?</em>  You must send the completed Form FDA 3486 to the Center for Biologics Evaluation and Research (CBER), either in paper or electronic format.</p>
<div id="p-606.171(e)(1)">
<p class="indent-2" data-title="606.171(e)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> If you make a paper filing, send the completed form to the CBER Document Control Center (see mailing address in <a href="/current/title-21/section-600.2#p-600.2(a)" class="cfr external">§ 600.2(a) of this chapter</a>), and identify on the envelope that a BPDR (biological product deviation report) is enclosed; or</p>
</div>
<div id="p-606.171(e)(2)">
<p class="indent-2" data-title="606.171(e)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> If you make an electronic filing, send the completed Form FDA3486 electronically using CBER's electronic Web-based application.</p>
</div>
</div>
<div id="p-606.171(f)"><p class="indent-1" data-title="606.171(f)"><span class="paragraph-hierarchy"><span class="paren">(</span>f<span class="paren">)</span></span> <em class="paragraph-heading">How does this regulation affect other FDA regulations?</em>  This part supplements and does not supersede other provisions of the regulations in this chapter. All biological product deviations, whether or not they are required to be reported under this section, should be investigated in accordance with the applicable provisions of <a href="/current/title-21/part-211" class="cfr external">parts 211</a>, <a href="/current/title-21/part-606" class="cfr external">606</a>, and <a href="/current/title-21/part-820" class="cfr external">820 of this chapter</a>.</p></div>
<p class="citation">[<a href="https://www.federalregister.gov/citation/65-FR-66635" class="fr-reference" data-reference="65 FR 66635">65 FR 66635</a>, Nov. 7, 2000, as amended at <a href="https://www.federalregister.gov/citation/70-FR-14984" class="fr-reference" data-reference="70 FR 14984">70 FR 14984</a>, Mar. 24, 2005; <a href="https://www.federalregister.gov/citation/80-FR-18092" class="fr-reference" data-reference="80 FR 18092">80 FR 18092</a>, Apr. 3, 2015]
</p>
</div>

</div>
</div><script type="application/json" id="source-and-authority-data">{"origins":[{"level":"part","identifier":"606","label_level":"Part 606","hierarchy":{"title":"21","chapter":"I","subchapter":"F","part":"606"},"current":true,"authority":["\u003ca href=\"https://www.govinfo.gov/link/uscode/21/321\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e21 U.S.C. 321\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/331\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e331\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/351\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e351\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/352\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e352\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/355\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e355\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/360\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e360\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/360j\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e360j\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/371\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e371\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/374\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e374\u003c/a\u003e; \u003ca href=\"https://www.govinfo.gov/link/uscode/42/216\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e42 U.S.C. 216\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/42/262\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e262\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/42/263a\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e263a\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/42/264\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e264\u003c/a\u003e.\n"],"source":["\u003ca href=\"https://www.federalregister.gov/citation/40-FR-53532\" class=\"fr-reference\" data-reference=\"40 FR 53532\"\u003e40 FR 53532\u003c/a\u003e, Nov. 18, 1975, unless otherwise noted.\n"],"link":"/current/title-21/part-606","title":"Part 606"}]}</script>

</div><div class="seal-block seal-block-footer"><h6>eCFR Content</h6></div></div>      </div>
    </div>
  </div>
</div>

        </div>
      </div>
    </div>

    <div class="site-footer container-fluid" id="footer">
  <div class="container">
    <div class="col-xs-12 col-md-12">
      <div class="row">
        <div class="col-xs-3 col-md-3">
          <h2>Pages</h2>
          <ul class="list with-bullets">
            <li><a href="/">Home</a></li>
            <li><a href="/">Titles</a></li>
            <li><a href="/search">Search</a></li>
            <li><a href="/recent-changes">Recent Changes</a></li>
            <li><a href="/corrections">Corrections</a></li>
          </ul>
        </div>

        <div class="col-xs-3 col-md-3">
          <h2>Reader Aids</h2>
          <ul class="list with-bullets">
              <li>
                <a href="https://www.ecfr.gov/reader-aids/using-ecfr">Using the eCFR Point-in-Time System</a>
              </li>
              <li>
                <a href="https://www.ecfr.gov/reader-aids/understanding-the-ecfr">Understanding the eCFR</a>
              </li>
              <li>
                <a href="https://www.ecfr.gov/reader-aids/government-policy-and-ofr-procedures">Government Policy and OFR Procedures</a>
              </li>
              <li>
                <a href="https://www.ecfr.gov/reader-aids/ecfr-developer-resources">Developer Resources</a>
              </li>
          </ul>
        </div>
        <div class="col-xs-3 col-md-3">
          <h2>Information</h2>
          <ul class="list with-bullets">
            <li><a href="/reader-aids/government-policy-and-ofr-procedures/about-this-site">About This Site</a></li>
            <li><a href="/reader-aids/government-policy-and-ofr-procedures/about-this-site#legal-status">Legal Status</a></li>
            <li><a href="/reader-aids/government-policy-and-ofr-procedures/privacy">Privacy</a></li>
            <li><a href="/reader-aids/government-policy-and-ofr-procedures/accessibility">Accessibility</a></li>
            <li><a href="/reader-aids/government-policy-and-ofr-procedures/foia">FOIA</a></li>
            <li><a href="https://www.archives.gov/eeo/policy/no-fear-notice.html">No Fear Act</a></li>
            <li><a href="https://www.archives.gov/federal-register/contact.html#coop">Continuity Information</a></li>
          </ul>
        </div>

        <div class="col-xs-3 col-md-3">
          <h2>My eCFR</h2>
          <ul class="list with-bullets">
            <li>
              <a href="/my/subscriptions">My Subscriptions</a>
            </li>
            <li>
              <a data-turbo="false" href="https://www.ecfr.gov/auth/sign_in?jwt=eyJhbGciOiJIUzI1NiJ9.eyJub3RpZmljYXRpb25zIjp7ImluZm8iOiJZb3Ugd2lsbCBiZSByZWRpcmVjdGVkIGJhY2sgdG8gdGhlIGVDRlIgYWZ0ZXIgeW91IGhhdmUgc2lnbmVkIGluIG9yIGNyZWF0ZWQgYW4gYWNjb3VudC4ifX0.-sYkHWfC02yb0CpuUqmPkxxnF0yzlNHaS5520hYIUy8&amp;redirect_to=https://www.ecfr.gov/current/title-21/chapter-I/subchapter-F/part-606">Sign In / Sign Up</a>
            </li>
          </ul>
        </div>


      </div>
    </div>
  </div>
</div>

</body></html>
